Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Risk of resistant avian influenza A virus in wild waterfowl as a result of environmental release of oseltamivir</title><author><name sortKey="Gillman, Anna" sort="Gillman, Anna" uniqKey="Gillman A" first="Anna" last="Gillman">Anna Gillman</name><affiliation><nlm:aff id="AF0001">Section for Infectious Diseases, Department of Medical Sciences, Uppsala University, Uppsala, Sweden</nlm:aff></affiliation><affiliation><nlm:aff id="AF0002">Zoonosis Science Centre, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">27733236</idno><idno type="pmc">5061866</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061866</idno><idno type="RBID">PMC:5061866</idno><idno type="doi">10.3402/iee.v6.32870</idno><date when="2016">2016</date><idno type="wicri:Area/Pmc/Corpus">000D70</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000D70</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Risk of resistant avian influenza A virus in wild waterfowl as a result of environmental release of oseltamivir</title><author><name sortKey="Gillman, Anna" sort="Gillman, Anna" uniqKey="Gillman A" first="Anna" last="Gillman">Anna Gillman</name><affiliation><nlm:aff id="AF0001">Section for Infectious Diseases, Department of Medical Sciences, Uppsala University, Uppsala, Sweden</nlm:aff></affiliation><affiliation><nlm:aff id="AF0002">Zoonosis Science Centre, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden</nlm:aff></affiliation></author></analytic><series><title level="j">Infection Ecology & Epidemiology</title><idno type="eISSN">2000-8686</idno><imprint><date when="2016">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Oseltamivir is the best available anti-influenza drug and has therefore been stockpiled worldwide in large quantities as part of influenza pandemic preparedness planning. The active metabolite oseltamivir carboxylate (OC) is stable and is not removed by conventional sewage treatment. Active OC has been detected in river water at concentrations up to 0.86 µg/L. Although the natural reservoir hosts of influenza A virus (IAV) are wild waterfowl that reside in aquatic environments, the ecologic risks associated with environmental OC release and its potential to generate resistant viral variants among wild birds has largely been unknown. However, in recent years a number of <italic>in vivo</italic> mallard (<italic>Anas platyrhynchos</italic>) studies have been conducted regarding the potential of avian IAVs to become resistant to OC in natural reservoir birds if these are drug exposed. Development of resistance to OC was observed both in Group 1 (N1) and Group 2 (N2, N9) neuraminidase subtypes, when infected ducks were exposed to OC at concentrations between 0.95 and 12 µg/L in their water. All resistant variants maintained replication and transmission between ducks during drug exposure. In an A(H1N1)/H274Y virus, the OC resistance mutation persisted without selective drug pressure, demonstrating the potential of an IAV with a permissive genetic background to acquire and maintain OC resistance, potentially allowing circulation of the resistant variant among wild birds. The experimental studies have improved the appreciation of the risks associated with the environmental release of OC related to resistance development of avian IAVs among wild birds. Combined with knowledge of efficient methods for improved sewage treatment, the observations warrant implementation of novel efficient wastewater treatment methods, rational use of anti-influenza drugs, and improved surveillance of IAV resistance in wild birds.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Fields, Bn" uniqKey="Fields B">BN Fields</name></author><author><name sortKey="Knipe, Dm" uniqKey="Knipe D">DM Knipe</name></author><author><name sortKey="Howley, Pm" uniqKey="Howley P">PM Howley</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Webster, Rg" uniqKey="Webster R">RG Webster</name></author><author><name sortKey="Bean, Wj" uniqKey="Bean W">WJ Bean</name></author><author><name sortKey="Gorman, Ot" uniqKey="Gorman O">OT Gorman</name></author><author><name sortKey="Chambers, Tm" uniqKey="Chambers T">TM Chambers</name></author><author><name sortKey="Kawaoka, Y" uniqKey="Kawaoka Y">Y Kawaoka</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Olsen, B" uniqKey="Olsen B">B Olsen</name></author><author><name sortKey="Munster, Vj" uniqKey="Munster V">VJ Munster</name></author><author><name sortKey="Wallensten, A" uniqKey="Wallensten A">A Wallensten</name></author><author><name sortKey="Waldenstrom, J" uniqKey="Waldenstrom J">J Waldenström</name></author><author><name sortKey="Osterhaus, Ad" uniqKey="Osterhaus A">AD Osterhaus</name></author><author><name sortKey="Fouchier, Ra" uniqKey="Fouchier R">RA Fouchier</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Brockwell Staats, C" uniqKey="Brockwell Staats C">C Brockwell-Staats</name></author><author><name sortKey="Webster, Rg" uniqKey="Webster R">RG Webster</name></author><author><name sortKey="Webby, Rj" uniqKey="Webby R">RJ Webby</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cox, Nj" uniqKey="Cox N">NJ Cox</name></author><author><name sortKey="Subbarao, K" uniqKey="Subbarao K">K Subbarao</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Monto, As" uniqKey="Monto A">AS Monto</name></author><author><name sortKey="Webster, Rg" uniqKey="Webster R">RG Webster</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="To, Kk" uniqKey="To K">KK To</name></author><author><name sortKey="Chan, Jf" uniqKey="Chan J">JF Chan</name></author><author><name sortKey="Chen, H" uniqKey="Chen H">H Chen</name></author><author><name sortKey="Li, L" uniqKey="Li L">L Li</name></author><author><name sortKey="Yuen, Ky" uniqKey="Yuen K">KY Yuen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Abdel Ghafar, An" uniqKey="Abdel Ghafar A">AN Abdel-Ghafar</name></author><author><name sortKey="Chotpitayasunondh, T" uniqKey="Chotpitayasunondh T">T Chotpitayasunondh</name></author><author><name sortKey="Gao, Z" uniqKey="Gao Z">Z Gao</name></author><author><name sortKey="Hayden, Fg" uniqKey="Hayden F">FG Hayden</name></author><author><name sortKey="Nguyen, Dh" uniqKey="Nguyen D">DH Nguyen</name></author><author><name sortKey="De Jong, Md" uniqKey="De Jong M">MD de Jong</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tanner, Wd" uniqKey="Tanner W">WD Tanner</name></author><author><name sortKey="Toth, Dj" uniqKey="Toth D">DJ Toth</name></author><author><name sortKey="Gundlapalli, Av" uniqKey="Gundlapalli A">AV Gundlapalli</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fiore, Ae" uniqKey="Fiore A">AE Fiore</name></author><author><name sortKey="Uyeki, Tm" uniqKey="Uyeki T">TM Uyeki</name></author><author><name sortKey="Broder, K" uniqKey="Broder K">K Broder</name></author><author><name sortKey="Finelli, L" uniqKey="Finelli L">L Finelli</name></author><author><name sortKey="Euler, Gl" uniqKey="Euler G">GL Euler</name></author><author><name sortKey="Singleton, Ja" uniqKey="Singleton J">JA Singleton</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Partridge, J" uniqKey="Partridge J">J Partridge</name></author><author><name sortKey="Kieny, Mp" uniqKey="Kieny M">MP Kieny</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nguyen Van Tam, Js" uniqKey="Nguyen Van Tam J">JS Nguyen-Van-Tam</name></author><author><name sortKey="Bresee, J" uniqKey="Bresee J">J Bresee</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Webster, Rg" uniqKey="Webster R">RG Webster</name></author><author><name sortKey="Govorkova, Ea" uniqKey="Govorkova E">EA Govorkova</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Hurt, Ac" uniqKey="Hurt A">AC Hurt</name></author><author><name sortKey="Besselaar, Tg" uniqKey="Besselaar T">TG Besselaar</name></author><author><name sortKey="Daniels, Rs" uniqKey="Daniels R">RS Daniels</name></author><author><name sortKey="Ermetal, B" uniqKey="Ermetal B">B Ermetal</name></author><author><name sortKey="Fry, A" uniqKey="Fry A">A Fry</name></author><author><name sortKey="Gubareva, L" uniqKey="Gubareva L">L Gubareva</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ison, Mg" uniqKey="Ison M">MG Ison</name></author><author><name sortKey="Hay, A" uniqKey="Hay A">A Hay</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Patel, A" uniqKey="Patel A">A Patel</name></author><author><name sortKey="Gorman, Se" uniqKey="Gorman S">SE Gorman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wan Po, Al" uniqKey="Wan Po A">AL Wan Po</name></author><author><name sortKey="Farndon, P" uniqKey="Farndon P">P Farndon</name></author><author><name sortKey="Palmer, N" uniqKey="Palmer N">N Palmer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Smith, Jr" uniqKey="Smith J">JR Smith</name></author><author><name sortKey="Rayner, Cr" uniqKey="Rayner C">CR Rayner</name></author><author><name sortKey="Donner, B" uniqKey="Donner B">B Donner</name></author><author><name sortKey="Wollenhaupt, M" uniqKey="Wollenhaupt M">M Wollenhaupt</name></author><author><name sortKey="Klumpp, K" uniqKey="Klumpp K">K Klumpp</name></author><author><name sortKey="Dutkowski, R" uniqKey="Dutkowski R">R Dutkowski</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Russell, Rj" uniqKey="Russell R">RJ Russell</name></author><author><name sortKey="Haire, Lf" uniqKey="Haire L">LF Haire</name></author><author><name sortKey="Stevens, Dj" uniqKey="Stevens D">DJ Stevens</name></author><author><name sortKey="Collins, Pj" uniqKey="Collins P">PJ Collins</name></author><author><name sortKey="Lin, Yp" uniqKey="Lin Y">YP Lin</name></author><author><name sortKey="Blackburn, Gm" uniqKey="Blackburn G">GM Blackburn</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Russel, Rj" uniqKey="Russel R">RJ Russel</name></author><author><name sortKey="Gamblin, Sj" uniqKey="Gamblin S">SJ Gamblin</name></author><author><name sortKey="Skehel, Jj" uniqKey="Skehel J">JJ Skehel</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Samson, M" uniqKey="Samson M">M Samson</name></author><author><name sortKey="Pizzorno, A" uniqKey="Pizzorno A">A Pizzorno</name></author><author><name sortKey="Abed, Y" uniqKey="Abed Y">Y Abed</name></author><author><name sortKey="Boivin, G" uniqKey="Boivin G">G Boivin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mckimm Breschkin, Jl" uniqKey="Mckimm Breschkin J">JL McKimm-Breschkin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Colman, Pm" uniqKey="Colman P">PM Colman</name></author><author><name sortKey="Hoyne, Pa" uniqKey="Hoyne P">PA Hoyne</name></author><author><name sortKey="Lawrence, Mc" uniqKey="Lawrence M">MC Lawrence</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ferraris, O" uniqKey="Ferraris O">O Ferraris</name></author><author><name sortKey="Lina, B" uniqKey="Lina B">B Lina</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tai, Cy" uniqKey="Tai C">CY Tai</name></author><author><name sortKey="Escarpe, Pa" uniqKey="Escarpe P">PA Escarpe</name></author><author><name sortKey="Sidwell, Rw" uniqKey="Sidwell R">RW Sidwell</name></author><author><name sortKey="Williams, Ma" uniqKey="Williams M">MA Williams</name></author><author><name sortKey="Lew, W" uniqKey="Lew W">W Lew</name></author><author><name sortKey="Wu, H" uniqKey="Wu H">H Wu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gubareva, Lv" uniqKey="Gubareva L">LV Gubareva</name></author><author><name sortKey="Robinson, Mj" uniqKey="Robinson M">MJ Robinson</name></author><author><name sortKey="Bethell, Rc" uniqKey="Bethell R">RC Bethell</name></author><author><name sortKey="Webster, Rg" uniqKey="Webster R">RG Webster</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mckimm Breschkin, Jl" uniqKey="Mckimm Breschkin J">JL McKimm-Breschkin</name></author><author><name sortKey="Sahasrabudhe, A" uniqKey="Sahasrabudhe A">A Sahasrabudhe</name></author><author><name sortKey="Blick, Tj" uniqKey="Blick T">TJ Blick</name></author><author><name sortKey="Mcdonald, M" uniqKey="Mcdonald M">M McDonald</name></author><author><name sortKey="Colman, Pm" uniqKey="Colman P">PM Colman</name></author><author><name sortKey="Hart, Gj" uniqKey="Hart G">GJ Hart</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kiso, M" uniqKey="Kiso M">M Kiso</name></author><author><name sortKey="Mitamura, K" uniqKey="Mitamura K">K Mitamura</name></author><author><name sortKey="Sakai Tagawa, Y" uniqKey="Sakai Tagawa Y">Y Sakai-Tagawa</name></author><author><name sortKey="Shiraishi, K" uniqKey="Shiraishi K">K Shiraishi</name></author><author><name sortKey="Kawakami, C" uniqKey="Kawakami C">C Kawakami</name></author><author><name sortKey="Kimura, K" uniqKey="Kimura K">K Kimura</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Whitley, Rj" uniqKey="Whitley R">RJ Whitley</name></author><author><name sortKey="Boucher, Ca" uniqKey="Boucher C">CA Boucher</name></author><author><name sortKey="Lina, B" uniqKey="Lina B">B Lina</name></author><author><name sortKey="Nguyen Van Tam, Js" uniqKey="Nguyen Van Tam J">JS Nguyen-Van-Tam</name></author><author><name sortKey="Osterhaus, A" uniqKey="Osterhaus A">A Osterhaus</name></author><author><name sortKey="Schutten, M" uniqKey="Schutten M">M Schutten</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gubareva, Lv" uniqKey="Gubareva L">LV Gubareva</name></author><author><name sortKey="Kaiser, L" uniqKey="Kaiser L">L Kaiser</name></author><author><name sortKey="Matrosovich, Mn" uniqKey="Matrosovich M">MN Matrosovich</name></author><author><name sortKey="Soo Hoo, Y" uniqKey="Soo Hoo Y">Y Soo-Hoo</name></author><author><name sortKey="Hayden, Fg" uniqKey="Hayden F">FG Hayden</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="De Jong, Md" uniqKey="De Jong M">MD De Jong</name></author><author><name sortKey="Tran, Tt" uniqKey="Tran T">TT Tran</name></author><author><name sortKey="Truong, Hk" uniqKey="Truong H">HK Truong</name></author><author><name sortKey="Vo, Mh" uniqKey="Vo M">MH Vo</name></author><author><name sortKey="Smith, Gj" uniqKey="Smith G">GJ Smith</name></author><author><name sortKey="Nguyen, Vc" uniqKey="Nguyen V">VC Nguyen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hu, Y" uniqKey="Hu Y">Y Hu</name></author><author><name sortKey="Lu, S" uniqKey="Lu S">S Lu</name></author><author><name sortKey="Song, Z" uniqKey="Song Z">Z Song</name></author><author><name sortKey="Wang, W" uniqKey="Wang W">W Wang</name></author><author><name sortKey="Hao, P" uniqKey="Hao P">P Hao</name></author><author><name sortKey="Li, J" uniqKey="Li J">J Li</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Eshaghi, A" uniqKey="Eshaghi A">A Eshaghi</name></author><author><name sortKey="Shalhoub, S" uniqKey="Shalhoub S">S Shalhoub</name></author><author><name sortKey="Rosenfeld, P" uniqKey="Rosenfeld P">P Rosenfeld</name></author><author><name sortKey="Li, A" uniqKey="Li A">A Li</name></author><author><name sortKey="Higgins, Rr" uniqKey="Higgins R">RR Higgins</name></author><author><name sortKey="Stogios, Pj" uniqKey="Stogios P">PJ Stogios</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Thorlund, K" uniqKey="Thorlund K">K Thorlund</name></author><author><name sortKey="Awad, T" uniqKey="Awad T">T Awad</name></author><author><name sortKey="Boivin, G" uniqKey="Boivin G">G Boivin</name></author><author><name sortKey="Thabane, L" uniqKey="Thabane L">L Thabane</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Van Der Vries, E" uniqKey="Van Der Vries E">E Van der Vries</name></author><author><name sortKey="Stelma, Ff" uniqKey="Stelma F">FF Stelma</name></author><author><name sortKey="Boucher, Ca" uniqKey="Boucher C">CA Boucher</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Moscona, A" uniqKey="Moscona A">A Moscona</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Storms, Ad" uniqKey="Storms A">AD Storms</name></author><author><name sortKey="Gubareva, Lv" uniqKey="Gubareva L">LV Gubareva</name></author><author><name sortKey="Su, S" uniqKey="Su S">S Su</name></author><author><name sortKey="Wheeling, Jt" uniqKey="Wheeling J">JT Wheeling</name></author><author><name sortKey="Okomo Adhiambo, M" uniqKey="Okomo Adhiambo M">M Okomo-Adhiambo</name></author><author><name sortKey="Pan, Cy" uniqKey="Pan C">CY Pan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lackenby, A" uniqKey="Lackenby A">A Lackenby</name></author><author><name sortKey="Moran Gilad, J" uniqKey="Moran Gilad J">J Moran Gilad</name></author><author><name sortKey="Pebody, R" uniqKey="Pebody R">R Pebody</name></author><author><name sortKey="Miah, S" uniqKey="Miah S">S Miah</name></author><author><name sortKey="Calatayud, L" uniqKey="Calatayud L">L Calatayud</name></author><author><name sortKey="Bolotin, S" uniqKey="Bolotin S">S Bolotin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Takashita, E" uniqKey="Takashita E">E Takashita</name></author><author><name sortKey="Kiso, M" uniqKey="Kiso M">M Kiso</name></author><author><name sortKey="Fujisaki, S" uniqKey="Fujisaki S">S Fujisaki</name></author><author><name sortKey="Yokoyama, M" uniqKey="Yokoyama M">M Yokoyama</name></author><author><name sortKey="Nakamura, K" uniqKey="Nakamura K">K Nakamura</name></author><author><name sortKey="Shirakura, M" uniqKey="Shirakura M">M Shirakura</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hurt, Ac" uniqKey="Hurt A">AC Hurt</name></author><author><name sortKey="Hardie, K" uniqKey="Hardie K">K Hardie</name></author><author><name sortKey="Wilson, Nj" uniqKey="Wilson N">NJ Wilson</name></author><author><name sortKey="Deng, Ym" uniqKey="Deng Y">YM Deng</name></author><author><name sortKey="Osbourn, M" uniqKey="Osbourn M">M Osbourn</name></author><author><name sortKey="Gehrig, N" uniqKey="Gehrig N">N Gehrig</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Stoner, Td" uniqKey="Stoner T">TD Stoner</name></author><author><name sortKey="Krauss, S" uniqKey="Krauss S">S Krauss</name></author><author><name sortKey="Turner, Jc" uniqKey="Turner J">JC Turner</name></author><author><name sortKey="Seiler, P" uniqKey="Seiler P">P Seiler</name></author><author><name sortKey="Negovetich, Nj" uniqKey="Negovetich N">NJ Negovetich</name></author><author><name sortKey="Stallknecht, De" uniqKey="Stallknecht D">DE Stallknecht</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Orozovic, G" uniqKey="Orozovic G">G Orozovic</name></author><author><name sortKey="Orozovic, K" uniqKey="Orozovic K">K Orozovic</name></author><author><name sortKey="J Rhult, Jd" uniqKey="J Rhult J">JD Järhult</name></author><author><name sortKey="Olsen, B" uniqKey="Olsen B">B Olsen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Stoner, Td" uniqKey="Stoner T">TD Stoner</name></author><author><name sortKey="Krauss, S" uniqKey="Krauss S">S Krauss</name></author><author><name sortKey="Dubois, Rm" uniqKey="Dubois R">RM DuBois</name></author><author><name sortKey="Negovetich, Nj" uniqKey="Negovetich N">NJ Negovetich</name></author><author><name sortKey="Stallknecht, De" uniqKey="Stallknecht D">DE Stallknecht</name></author><author><name sortKey="Senne, Da" uniqKey="Senne D">DA Senne</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Fick, J" uniqKey="Fick J">J Fick</name></author><author><name sortKey="Lindberg, Rh" uniqKey="Lindberg R">RH Lindberg</name></author><author><name sortKey="Tysklind, M" uniqKey="Tysklind M">M Tysklind</name></author><author><name sortKey="Haemig, Pd" uniqKey="Haemig P">PD Haemig</name></author><author><name sortKey="Waldenstrom, J" uniqKey="Waldenstrom J">J Waldenström</name></author><author><name sortKey="Wallensten, A" uniqKey="Wallensten A">A Wallensten</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jain, S" uniqKey="Jain S">S Jain</name></author><author><name sortKey="Kumar, P" uniqKey="Kumar P">P Kumar</name></author><author><name sortKey="Vyas, Rk" uniqKey="Vyas R">RK Vyas</name></author><author><name sortKey="Pandit, P" uniqKey="Pandit P">P Pandit</name></author><author><name sortKey="Dalai, Ak" uniqKey="Dalai A">AK Dalai</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Azuma, T" uniqKey="Azuma T">T Azuma</name></author><author><name sortKey="Nakada, N" uniqKey="Nakada N">N Nakada</name></author><author><name sortKey="Yamashita, N" uniqKey="Yamashita N">N Yamashita</name></author><author><name sortKey="Tanaka, H" uniqKey="Tanaka H">H Tanaka</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Leknes, H" uniqKey="Leknes H">H Leknes</name></author><author><name sortKey="Sturtzel, Ie" uniqKey="Sturtzel I">IE Sturtzel</name></author><author><name sortKey="Dye, C" uniqKey="Dye C">C Dye</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Singer, Ac" uniqKey="Singer A">AC Singer</name></author><author><name sortKey="J Rhult, Jd" uniqKey="J Rhult J">JD Järhult</name></author><author><name sortKey="Grabic, R" uniqKey="Grabic R">R Grabic</name></author><author><name sortKey="Khan, Ga" uniqKey="Khan G">GA Khan</name></author><author><name sortKey="Lindberg, Rh" uniqKey="Lindberg R">RH Lindberg</name></author><author><name sortKey="Fedorova, G" uniqKey="Fedorova G">G Fedorova</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ghosh, Gc" uniqKey="Ghosh G">GC Ghosh</name></author><author><name sortKey="Nakada, N" uniqKey="Nakada N">N Nakada</name></author><author><name sortKey="Yamashita, N" uniqKey="Yamashita N">N Yamashita</name></author><author><name sortKey="Tanaka, H" uniqKey="Tanaka H">H Tanaka</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Prasse, C" uniqKey="Prasse C">C Prasse</name></author><author><name sortKey="Schlusener, Mp" uniqKey="Schlusener M">MP Schlusener</name></author><author><name sortKey="Schulz, R" uniqKey="Schulz R">R Schulz</name></author><author><name sortKey="Ternes, Ta" uniqKey="Ternes T">TA Ternes</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Azuma, T" uniqKey="Azuma T">T Azuma</name></author><author><name sortKey="Ishiuchi, H" uniqKey="Ishiuchi H">H Ishiuchi</name></author><author><name sortKey="Inoyama, T" uniqKey="Inoyama T">T Inoyama</name></author><author><name sortKey="Teranishi, Y" uniqKey="Teranishi Y">Y Teranishi</name></author><author><name sortKey="Yamaoka, M" uniqKey="Yamaoka M">M Yamaoka</name></author><author><name sortKey="Sato, T" uniqKey="Sato T">T Sato</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tashiro, M" uniqKey="Tashiro M">M Tashiro</name></author><author><name sortKey="Mckimm Breschkin, Jl" uniqKey="Mckimm Breschkin J">JL McKimm-Breschkin</name></author><author><name sortKey="Saito, T" uniqKey="Saito T">T Saito</name></author><author><name sortKey="Klimov, A" uniqKey="Klimov A">A Klimov</name></author><author><name sortKey="Macken, C" uniqKey="Macken C">C Macken</name></author><author><name sortKey="Zambon, M" uniqKey="Zambon M">M Zambon</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Soderstrom, H" uniqKey="Soderstrom H">H Söderström</name></author><author><name sortKey="J Rhult, Jd" uniqKey="J Rhult J">JD Järhult</name></author><author><name sortKey="Olsen, B" uniqKey="Olsen B">B Olsen</name></author><author><name sortKey="Lindberg, Rh" uniqKey="Lindberg R">RH Lindberg</name></author><author><name sortKey="Tanaka, H" uniqKey="Tanaka H">H Tanaka</name></author><author><name sortKey="Fick, J" uniqKey="Fick J">J Fick</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Takanami, R" uniqKey="Takanami R">R Takanami</name></author><author><name sortKey="Ozaki, H" uniqKey="Ozaki H">H Ozaki</name></author><author><name sortKey="Giri, Rr" uniqKey="Giri R">RR Giri</name></author><author><name sortKey="Taniguchi, S" uniqKey="Taniguchi S">S Taniguchi</name></author><author><name sortKey="Hayashi, S" uniqKey="Hayashi S">S Hayashi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Takanami, R" uniqKey="Takanami R">R Takanami</name></author><author><name sortKey="Ozaki, H" uniqKey="Ozaki H">H Ozaki</name></author><author><name sortKey="Giri, Rr" uniqKey="Giri R">RR Giri</name></author><author><name sortKey="Taniguchi, S" uniqKey="Taniguchi S">S Taniguchi</name></author><author><name sortKey="Hayashi, S" uniqKey="Hayashi S">S Hayashi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ghosh, Gc" uniqKey="Ghosh G">GC Ghosh</name></author><author><name sortKey="Nakada, N" uniqKey="Nakada N">N Nakada</name></author><author><name sortKey="Yamashita, N" uniqKey="Yamashita N">N Yamashita</name></author><author><name sortKey="Tanaka, H" uniqKey="Tanaka H">H Tanaka</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Azuma, T" uniqKey="Azuma T">T Azuma</name></author><author><name sortKey="Nakada, N" uniqKey="Nakada N">N Nakada</name></author><author><name sortKey="Yamashita, N" uniqKey="Yamashita N">N Yamashita</name></author><author><name sortKey="Tanaka, H" uniqKey="Tanaka H">H Tanaka</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Singer, Ac" uniqKey="Singer A">AC Singer</name></author><author><name sortKey="J Rhult, Jd" uniqKey="J Rhult J">JD Järhult</name></author><author><name sortKey="Grabic, R" uniqKey="Grabic R">R Grabic</name></author><author><name sortKey="Khan, Ga" uniqKey="Khan G">GA Khan</name></author><author><name sortKey="Fedorova, G" uniqKey="Fedorova G">G Fedorova</name></author><author><name sortKey="Fick, J" uniqKey="Fick J">J Fick</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Goncalves, C" uniqKey="Goncalves C">C Goncalves</name></author><author><name sortKey="Perez, S" uniqKey="Perez S">S Perez</name></author><author><name sortKey="Osorio, V" uniqKey="Osorio V">V Osorio</name></author><author><name sortKey="Petrovic, M" uniqKey="Petrovic M">M Petrovic</name></author><author><name sortKey="Alpendurada, Mf" uniqKey="Alpendurada M">MF Alpendurada</name></author><author><name sortKey="Barcelo, D" uniqKey="Barcelo D">D Barcelo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chen, Wy" uniqKey="Chen W">WY Chen</name></author><author><name sortKey="Lin, Cj" uniqKey="Lin C">CJ Lin</name></author><author><name sortKey="Liao, Cm" uniqKey="Liao C">CM Liao</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Straub, Jo" uniqKey="Straub J">JO Straub</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Singer, Ac" uniqKey="Singer A">AC Singer</name></author><author><name sortKey="Johnson, Ac" uniqKey="Johnson A">AC Johnson</name></author><author><name sortKey="Anderson, Pd" uniqKey="Anderson P">PD Anderson</name></author><author><name sortKey="Snyder, Sa" uniqKey="Snyder S">SA Snyder</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Singer, Ac" uniqKey="Singer A">AC Singer</name></author><author><name sortKey="Nunn, Ma" uniqKey="Nunn M">MA Nunn</name></author><author><name sortKey="Gould, Ea" uniqKey="Gould E">EA Gould</name></author><author><name sortKey="Johnson, Ac" uniqKey="Johnson A">AC Johnson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bartels, P" uniqKey="Bartels P">P Bartels</name></author><author><name sortKey="Von Tumpling, W" uniqKey="Von Tumpling W">W von Tumpling</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Boreen, Al" uniqKey="Boreen A">AL Boreen</name></author><author><name sortKey="Arnold, Wa" uniqKey="Arnold W">WA Arnold</name></author><author><name sortKey="Mcneill, K" uniqKey="Mcneill K">K McNeill</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Accinelli, C" uniqKey="Accinelli C">C Accinelli</name></author><author><name sortKey="Sacca, Ml" uniqKey="Sacca M">ML Sacca</name></author><author><name sortKey="Fick, J" uniqKey="Fick J">J Fick</name></author><author><name sortKey="Mencarelli, M" uniqKey="Mencarelli M">M Mencarelli</name></author><author><name sortKey="Lindberg, R" uniqKey="Lindberg R">R Lindberg</name></author><author><name sortKey="Olsen, B" uniqKey="Olsen B">B Olsen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Accinelli, C" uniqKey="Accinelli C">C Accinelli</name></author><author><name sortKey="Caracciolo, Ab" uniqKey="Caracciolo A">AB Caracciolo</name></author><author><name sortKey="Grenni, P" uniqKey="Grenni P">P Grenni</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Slater, Fr" uniqKey="Slater F">FR Slater</name></author><author><name sortKey="Singer, Ac" uniqKey="Singer A">AC Singer</name></author><author><name sortKey="Turner, S" uniqKey="Turner S">S Turner</name></author><author><name sortKey="Barr, Jj" uniqKey="Barr J">JJ Barr</name></author><author><name sortKey="Bond, Pl" uniqKey="Bond P">PL Bond</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sacca, Ml" uniqKey="Sacca M">ML Sacca</name></author><author><name sortKey="Accinelli, C" uniqKey="Accinelli C">C Accinelli</name></author><author><name sortKey="Fick, J" uniqKey="Fick J">J Fick</name></author><author><name sortKey="Lindberg, R" uniqKey="Lindberg R">R Lindberg</name></author><author><name sortKey="Olsen, B" uniqKey="Olsen B">B Olsen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Accinelli, C" uniqKey="Accinelli C">C Accinelli</name></author><author><name sortKey="Sacca, Ml" uniqKey="Sacca M">ML Saccà</name></author><author><name sortKey="Batisson, I" uniqKey="Batisson I">I Batisson</name></author><author><name sortKey="Fick, J" uniqKey="Fick J">J Fick</name></author><author><name sortKey="Mencarelli, M" uniqKey="Mencarelli M">M Mencarelli</name></author><author><name sortKey="Grabic, R" uniqKey="Grabic R">R Grabic</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mestankova, H" uniqKey="Mestankova H">H Mestankova</name></author><author><name sortKey="Schirmer, K" uniqKey="Schirmer K">K Schirmer</name></author><author><name sortKey="Escher, Bi" uniqKey="Escher B">BI Escher</name></author><author><name sortKey="Von Gunten, U" uniqKey="Von Gunten U">U von Gunten</name></author><author><name sortKey="Canonica, S" uniqKey="Canonica S">S Canonica</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fedorova, G" uniqKey="Fedorova G">G Fedorova</name></author><author><name sortKey="Grabic, R" uniqKey="Grabic R">R Grabic</name></author><author><name sortKey="Nyhlen, J" uniqKey="Nyhlen J">J Nyhlen</name></author><author><name sortKey="J Rhult, Jd" uniqKey="J Rhult J">JD Järhult</name></author><author><name sortKey="Soderstrom, H" uniqKey="Soderstrom H">H Söderström</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Munster, Vj" uniqKey="Munster V">VJ Munster</name></author><author><name sortKey="Baas, C" uniqKey="Baas C">C Baas</name></author><author><name sortKey="Lexmond, P" uniqKey="Lexmond P">P Lexmond</name></author><author><name sortKey="Waldenstrom, J" uniqKey="Waldenstrom J">J Waldenström</name></author><author><name sortKey="Wallensten, A" uniqKey="Wallensten A">A Wallensten</name></author><author><name sortKey="Fransson, T" uniqKey="Fransson T">T Fransson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Krauss, S" uniqKey="Krauss S">S Krauss</name></author><author><name sortKey="Walker, D" uniqKey="Walker D">D Walker</name></author><author><name sortKey="Pryor, Sp" uniqKey="Pryor S">SP Pryor</name></author><author><name sortKey="Niles, L" uniqKey="Niles L">L Niles</name></author><author><name sortKey="Chenghong, L" uniqKey="Chenghong L">L Chenghong</name></author><author><name sortKey="Hinshaw, Vs" uniqKey="Hinshaw V">VS Hinshaw</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fouchier, Ram" uniqKey="Fouchier R">RAM Fouchier</name></author><author><name sortKey="Guan, Y" uniqKey="Guan Y">Y Guan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Latorre Margalef, N" uniqKey="Latorre Margalef N">N Latorre-Margalef</name></author><author><name sortKey="Tolf, C" uniqKey="Tolf C">C Tolf</name></author><author><name sortKey="Grosbois, V" uniqKey="Grosbois V">V Grosbois</name></author><author><name sortKey="Avril, A" uniqKey="Avril A">A Avril</name></author><author><name sortKey="Bengtsson, D" uniqKey="Bengtsson D">D Bengtsson</name></author><author><name sortKey="Wille, M" uniqKey="Wille M">M Wille</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gaidet, N" uniqKey="Gaidet N">N Gaidet</name></author><author><name sortKey="Ould El Mamy, Ab" uniqKey="Ould El Mamy A">AB Ould El Mamy</name></author><author><name sortKey="Cappelle, J" uniqKey="Cappelle J">J Cappelle</name></author><author><name sortKey="Caron, A" uniqKey="Caron A">A Caron</name></author><author><name sortKey="Cumming, Gs" uniqKey="Cumming G">GS Cumming</name></author><author><name sortKey="Grosbois, V" uniqKey="Grosbois V">V Grosbois</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Krauss, S" uniqKey="Krauss S">S Krauss</name></author><author><name sortKey="Stallknecht, De" uniqKey="Stallknecht D">DE Stallknecht</name></author><author><name sortKey="Negovetich, Nj" uniqKey="Negovetich N">NJ Negovetich</name></author><author><name sortKey="Niles, Lj" uniqKey="Niles L">LJ Niles</name></author><author><name sortKey="Webby, Rj" uniqKey="Webby R">RJ Webby</name></author><author><name sortKey="Webster, Rg" uniqKey="Webster R">RG Webster</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jourdain, E" uniqKey="Jourdain E">E Jourdain</name></author><author><name sortKey="Gunnarsson, G" uniqKey="Gunnarsson G">G Gunnarsson</name></author><author><name sortKey="Wahlgren, J" uniqKey="Wahlgren J">J Wahlgren</name></author><author><name sortKey="Latorre Margalef, N" uniqKey="Latorre Margalef N">N Latorre-Margalef</name></author><author><name sortKey="Brojer, C" uniqKey="Brojer C">C Bröjer</name></author><author><name sortKey="Sahlin, S" uniqKey="Sahlin S">S Sahlin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Latorre Margalef, N" uniqKey="Latorre Margalef N">N Latorre-Margalef</name></author><author><name sortKey="Gunnarsson, G" uniqKey="Gunnarsson G">G Gunnarsson</name></author><author><name sortKey="Munster, Vj" uniqKey="Munster V">VJ Munster</name></author><author><name sortKey="Fouchier, Ra" uniqKey="Fouchier R">RA Fouchier</name></author><author><name sortKey="Osterhaus, Ad" uniqKey="Osterhaus A">AD Osterhaus</name></author><author><name sortKey="Elmberg, J" uniqKey="Elmberg J">J Elmberg</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wallensten, A" uniqKey="Wallensten A">A Wallensten</name></author><author><name sortKey="Munster, Vj" uniqKey="Munster V">VJ Munster</name></author><author><name sortKey="Karlsson, M" uniqKey="Karlsson M">M Karlsson</name></author><author><name sortKey="Lundkvist, " uniqKey="Lundkvist ">Å Lundkvist</name></author><author><name sortKey="Brytting, M" uniqKey="Brytting M">M Brytting</name></author><author><name sortKey="Stervander, M" uniqKey="Stervander M">M Stervander</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hill, Nj" uniqKey="Hill N">NJ Hill</name></author><author><name sortKey="Takekawa, Jy" uniqKey="Takekawa J">JY Takekawa</name></author><author><name sortKey="Ackerman, Jt" uniqKey="Ackerman J">JT Ackerman</name></author><author><name sortKey="Hobson, Ka" uniqKey="Hobson K">KA Hobson</name></author><author><name sortKey="Herring, G" uniqKey="Herring G">G Herring</name></author><author><name sortKey="Cardona, Cj" uniqKey="Cardona C">CJ Cardona</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lewis, Ns" uniqKey="Lewis N">NS Lewis</name></author><author><name sortKey="Verhagen, Jh" uniqKey="Verhagen J">JH Verhagen</name></author><author><name sortKey="Javakhishvili, Z" uniqKey="Javakhishvili Z">Z Javakhishvili</name></author><author><name sortKey="Russell, Ca" uniqKey="Russell C">CA Russell</name></author><author><name sortKey="Lexmond, P" uniqKey="Lexmond P">P Lexmond</name></author><author><name sortKey="Westgeest, Kb" uniqKey="Westgeest K">KB Westgeest</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dugan, Vg" uniqKey="Dugan V">VG Dugan</name></author><author><name sortKey="Chen, R" uniqKey="Chen R">R Chen</name></author><author><name sortKey="Spiro, Dj" uniqKey="Spiro D">DJ Spiro</name></author><author><name sortKey="Sengamalay, N" uniqKey="Sengamalay N">N Sengamalay</name></author><author><name sortKey="Zaborsky, J" uniqKey="Zaborsky J">J Zaborsky</name></author><author><name sortKey="Ghedin, E" uniqKey="Ghedin E">E Ghedin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chen, R" uniqKey="Chen R">R Chen</name></author><author><name sortKey="Holmes, Ec" uniqKey="Holmes E">EC Holmes</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Russell, Ca" uniqKey="Russell C">CA Russell</name></author><author><name sortKey="Fonville, Jm" uniqKey="Fonville J">JM Fonville</name></author><author><name sortKey="Brown, Ae" uniqKey="Brown A">AE Brown</name></author><author><name sortKey="Burke, Df" uniqKey="Burke D">DF Burke</name></author><author><name sortKey="Smith, Dl" uniqKey="Smith D">DL Smith</name></author><author><name sortKey="James, Sl" uniqKey="James S">SL James</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chen, R" uniqKey="Chen R">R Chen</name></author><author><name sortKey="Holmes, Ec" uniqKey="Holmes E">EC Holmes</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Forrest, Hl" uniqKey="Forrest H">HL Forrest</name></author><author><name sortKey="Webster, Rg" uniqKey="Webster R">RG Webster</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="J Rhult, Jd" uniqKey="J Rhult J">JD Järhult</name></author><author><name sortKey="Muradrasoli, S" uniqKey="Muradrasoli S">S Muradrasoli</name></author><author><name sortKey="Wahlgren, J" uniqKey="Wahlgren J">J Wahlgren</name></author><author><name sortKey="Soderstrom, H" uniqKey="Soderstrom H">H Söderström</name></author><author><name sortKey="Orozovic, G" uniqKey="Orozovic G">G Orozovic</name></author><author><name sortKey="Gunnarsson, G" uniqKey="Gunnarsson G">G Gunnarsson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Achenbach, Je" uniqKey="Achenbach J">JE Achenbach</name></author><author><name sortKey="Bowen, Ra" uniqKey="Bowen R">RA Bowen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gillman, A" uniqKey="Gillman A">A Gillman</name></author><author><name sortKey="Muradrasoli, S" uniqKey="Muradrasoli S">S Muradrasoli</name></author><author><name sortKey="Soderstrom, H" uniqKey="Soderstrom H">H Söderström</name></author><author><name sortKey="Nordh, J" uniqKey="Nordh J">J Nordh</name></author><author><name sortKey="Brojer, C" uniqKey="Brojer C">C Bröjer</name></author><author><name sortKey="Lindberg, Rh" uniqKey="Lindberg R">RH Lindberg</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gillman, A" uniqKey="Gillman A">A Gillman</name></author><author><name sortKey="Nykvist, M" uniqKey="Nykvist M">M Nykvist</name></author><author><name sortKey="Muradrasoli, S" uniqKey="Muradrasoli S">S Muradrasoli</name></author><author><name sortKey="Soderstrom, H" uniqKey="Soderstrom H">H Söderström</name></author><author><name sortKey="Wille, M" uniqKey="Wille M">M Wille</name></author><author><name sortKey="Daggfeldt, A" uniqKey="Daggfeldt A">A Daggfeldt</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gillman, A" uniqKey="Gillman A">A Gillman</name></author><author><name sortKey="Muradrasoli, S" uniqKey="Muradrasoli S">S Muradrasoli</name></author><author><name sortKey="Soderstrom, H" uniqKey="Soderstrom H">H Söderström</name></author><author><name sortKey="Holmberg, F" uniqKey="Holmberg F">F Holmberg</name></author><author><name sortKey="Latorre Margalef, N" uniqKey="Latorre Margalef N">N Latorre-Margalef</name></author><author><name sortKey="Tolf, C" uniqKey="Tolf C">C Tolf</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gillman, A" uniqKey="Gillman A">A Gillman</name></author><author><name sortKey="Muradrasoli, S" uniqKey="Muradrasoli S">S Muradrasoli</name></author><author><name sortKey="Mardnas, A" uniqKey="Mardnas A">A Mardnas</name></author><author><name sortKey="Soderstrom, H" uniqKey="Soderstrom H">H Söderström</name></author><author><name sortKey="Fedorova, G" uniqKey="Fedorova G">G Fedorova</name></author><author><name sortKey="Lowenthal, M" uniqKey="Lowenthal M">M Lowenthal</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bloom, Jd" uniqKey="Bloom J">JD Bloom</name></author><author><name sortKey="Gong, Li" uniqKey="Gong L">LI Gong</name></author><author><name sortKey="Baltimore, D" uniqKey="Baltimore D">D Baltimore</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Duan, S" uniqKey="Duan S">S Duan</name></author><author><name sortKey="Govorkova, Ea" uniqKey="Govorkova E">EA Govorkova</name></author><author><name sortKey="Bahl, J" uniqKey="Bahl J">J Bahl</name></author><author><name sortKey="Zaraket, H" uniqKey="Zaraket H">H Zaraket</name></author><author><name sortKey="Baranovich, T" uniqKey="Baranovich T">T Baranovich</name></author><author><name sortKey="Seiler, P" uniqKey="Seiler P">P Seiler</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Butler, J" uniqKey="Butler J">J Butler</name></author><author><name sortKey="Hooper, Ka" uniqKey="Hooper K">KA Hooper</name></author><author><name sortKey="Petrie, S" uniqKey="Petrie S">S Petrie</name></author><author><name sortKey="Lee, R" uniqKey="Lee R">R Lee</name></author><author><name sortKey="Maurer Stroh, S" uniqKey="Maurer Stroh S">S Maurer-Stroh</name></author><author><name sortKey="Reh, L" uniqKey="Reh L">L Reh</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="review-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Infect Ecol Epidemiol</journal-id><journal-id journal-id-type="iso-abbrev">Infect Ecol Epidemiol</journal-id><journal-id journal-id-type="publisher-id">IEE</journal-id><journal-title-group><journal-title>Infection Ecology & Epidemiology</journal-title></journal-title-group><issn pub-type="epub">2000-8686</issn><publisher><publisher-name>Co-Action Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27733236</article-id><article-id pub-id-type="pmc">5061866</article-id><article-id pub-id-type="publisher-id">32870</article-id><article-id pub-id-type="doi">10.3402/iee.v6.32870</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Risk of resistant avian influenza A virus in wild waterfowl as a result of environmental release of oseltamivir</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gillman</surname><given-names>Anna</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="AF0001">1</xref><xref ref-type="aff" rid="AF0002">2</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="AF0001"><label>1</label>Section for Infectious Diseases, Department of Medical Sciences, Uppsala University, Uppsala, Sweden</aff><aff id="AF0002"><label>2</label>Zoonosis Science Centre, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden</aff><author-notes><corresp id="cor1"><label>*</label>Correspondence to: Anna Gillman, Section for Infectious Diseases, Department of Medical Sciences, Uppsala University, Ing 34, SE-75185 Uppsala, Sweden, Email: <email xlink:href="anna.gillman@medsci.uu.se">anna.gillman@medsci.uu.se</email></corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>10</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>6</volume><elocation-id content-type="doi">10.3402/iee.v6.32870</elocation-id><history><date date-type="received"><day>12</day><month>7</month><year>2016</year></date><date date-type="rev-recd"><day>12</day><month>9</month><year>2016</year></date><date date-type="accepted"><day>13</day><month>9</month><year>2016</year></date></history><permissions><copyright-statement>© 2016 Anna Gillman</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Oseltamivir is the best available anti-influenza drug and has therefore been stockpiled worldwide in large quantities as part of influenza pandemic preparedness planning. The active metabolite oseltamivir carboxylate (OC) is stable and is not removed by conventional sewage treatment. Active OC has been detected in river water at concentrations up to 0.86 µg/L. Although the natural reservoir hosts of influenza A virus (IAV) are wild waterfowl that reside in aquatic environments, the ecologic risks associated with environmental OC release and its potential to generate resistant viral variants among wild birds has largely been unknown. However, in recent years a number of <italic>in vivo</italic> mallard (<italic>Anas platyrhynchos</italic>) studies have been conducted regarding the potential of avian IAVs to become resistant to OC in natural reservoir birds if these are drug exposed. Development of resistance to OC was observed both in Group 1 (N1) and Group 2 (N2, N9) neuraminidase subtypes, when infected ducks were exposed to OC at concentrations between 0.95 and 12 µg/L in their water. All resistant variants maintained replication and transmission between ducks during drug exposure. In an A(H1N1)/H274Y virus, the OC resistance mutation persisted without selective drug pressure, demonstrating the potential of an IAV with a permissive genetic background to acquire and maintain OC resistance, potentially allowing circulation of the resistant variant among wild birds. The experimental studies have improved the appreciation of the risks associated with the environmental release of OC related to resistance development of avian IAVs among wild birds. Combined with knowledge of efficient methods for improved sewage treatment, the observations warrant implementation of novel efficient wastewater treatment methods, rational use of anti-influenza drugs, and improved surveillance of IAV resistance in wild birds.</p></abstract><kwd-group><kwd>influenza A</kwd><kwd>avian influenza</kwd><kwd>resistance</kwd><kwd>oseltamivir</kwd><kwd>environmental</kwd><kwd>mallard</kwd><kwd>antiviral resistance</kwd><kwd>sewage treatment</kwd></kwd-group></article-meta></front><body><p>Influenza A virus (IAV) belongs to the Orthomyxoviridae family and is an enveloped, negative-sense single-stranded RNA virus with a segmented genome (<xref rid="CIT0001" ref-type="bibr">1</xref>) that can infect many animal species, including humans, although the major natural reservoir hosts are wild waterfowl (<xref rid="CIT0002" ref-type="bibr">2</xref>, <xref rid="CIT0003" ref-type="bibr">3</xref>).</p><p>All known human IAVs contain genetic segments that originate from IAVs of wild birds (<xref rid="CIT0004" ref-type="bibr">4</xref>, <xref rid="CIT0005" ref-type="bibr">5</xref>). If an avian (or swine) origin IAV with new antigenic properties and with the ability to efficiently replicate and transmit between humans is introduced to the human population, a rapid and widespread pandemic disease can occur, as was the case with the Spanish flu (H1N1) in 1918–1919, the Asian flu (H2N2) in 1957, the Hong Kong flu (H3N2) in 1968, and the swine flu (H1N1) in 2009 (<xref rid="CIT0004" ref-type="bibr">4</xref>, <xref rid="CIT0005" ref-type="bibr">5</xref>). Pandemic viruses often give rise to severe disease with high mortality (<xref rid="CIT0002" ref-type="bibr">2</xref>, <xref rid="CIT0006" ref-type="bibr">6</xref>), but as a result of acquired immunity in the population and antigenic drift of the virus the severity is then gradually reduced to a moderate airway disease when pandemic viruses continue to circulate as new seasonal IAV variants (<xref rid="CIT0001" ref-type="bibr">1</xref>, <xref rid="CIT0005" ref-type="bibr">5</xref>). Thus far only the H1N1, H2N2, and H3N2 subtypes have caused widespread human disease and become human-adapted viruses (<xref rid="CIT0002" ref-type="bibr">2</xref>, <xref rid="CIT0004" ref-type="bibr">4</xref>, <xref rid="CIT0005" ref-type="bibr">5</xref>). However, aside from human-adapted viruses, avian IAVs may occasionally infect humans and can sometimes give rise to very severe generalized disease with high mortality, as is the case with the highly pathogenic avian influenza (HPAI) A(H5N1) virus and the Chinese influenza A(H7N9) virus (<xref rid="CIT0007" ref-type="bibr">7</xref>–<xref rid="CIT0009" ref-type="bibr">9</xref>).</p><p>The ideal means of prevention of human IAV infections is vaccination, which reduces morbidity and mortality (<xref rid="CIT0010" ref-type="bibr">10</xref>). However, a disadvantage with influenza vaccines for the prevention of seasonal influenza is that they are made well in advance of the influenza season and the actual circulating variants may not perfectly match the antigenicity of the chosen vaccine strains. Regarding pandemic vaccines, a major drawback is that they cannot be made in advance as the antigenicity remains unknown until the virus emerges and thus the final distribution of a new vaccine can only be achieved after several months (<xref rid="CIT0011" ref-type="bibr">11</xref>, <xref rid="CIT0012" ref-type="bibr">12</xref>). Therefore, a cornerstone in the treatment and prevention of new human pathogenic influenza viruses, as well as of severe seasonal cases, is direct anti-influenza drugs.</p><sec id="S0002"><title>Neuraminidase inhibitors and resistance</title><p>Since the widespread global resistance to the adamantane M2 ion channel inhibitors in the mid-2000s (<xref rid="CIT0013" ref-type="bibr">13</xref>, <xref rid="CIT0014" ref-type="bibr">14</xref>), the neuraminidase inhibitors (NAIs) have been the best drugs available to treat severe influenza infections (<xref rid="CIT0015" ref-type="bibr">15</xref>). Zanamivir (ZA) and oseltamivir have been globally approved since 1999, whereas peramivir and laninamivir have been approved in Japan and a few other countries since 2010 (<xref rid="CIT0013" ref-type="bibr">13</xref>, <xref rid="CIT0016" ref-type="bibr">16</xref>).</p><p>Among the NAIs the orally available oseltamivir (Tamiflu<sup>®</sup>) is the most used and is the primary drug that has been stockpiled worldwide as part of pandemic preparedness planning (<xref rid="CIT0017" ref-type="bibr">17</xref>, <xref rid="CIT0018" ref-type="bibr">18</xref>). After oral administration of the ethyl ester prodrug oseltamivir phosphate, which is converted by liver esterase, 75% of an oral dose reaches the plasma as active oseltamivir carboxylate (OC), which is then eliminated unchanged in the urine (<xref rid="CIT0019" ref-type="bibr">19</xref>). OC and all other NAIs act by competitive binding to the extracellular enzymatic site of the neuraminidase (NA) protein. Thereby, the NA binding and the catalytic destruction of its sialic acid targets is inhibited and the release of newly formed virions from infected cells and viral spread through respiratory secretions is reduced (<xref rid="CIT0016" ref-type="bibr">16</xref>). NAI binding to the enzymatic target differs slightly between the structurally different neuraminidase (NA) proteins (<xref rid="CIT0020" ref-type="bibr">20</xref>), which are phylogenetically grouped to Group 1 (including subtypes N1, N4, N5, N8) and Group 2 (including subtypes N2, N3, N6, N7 and N9) (<xref rid="CIT0001" ref-type="bibr">1</xref>, <xref rid="CIT0021" ref-type="bibr">21</xref>).</p><p>The NA group–specific differences also have implications for which resistance-related amino acid substitutions may evolve under drug pressure (<xref rid="CIT0022" ref-type="bibr">22</xref>, <xref rid="CIT0023" ref-type="bibr">23</xref>). Resistance to NAIs is primarily caused by amino acid substitutions in the NA protein leading to reduced binding of the drugs, either by substitution of active site residues or of framework residues (<xref rid="CIT0022" ref-type="bibr">22</xref>, <xref rid="CIT0024" ref-type="bibr">24</xref>). In IAVs containing N1 NA proteins the most common resistance-related change seen <italic>in vivo</italic> is the framework substitution H274Y (N2 numbering, used hereafter), whereas in N2-containing viruses the framework E119V and active-site R292K substitutions are most commonly described (<xref rid="CIT0022" ref-type="bibr">22</xref>, <xref rid="CIT0025" ref-type="bibr">25</xref>).</p><p>Resistance to OC and ZA was described <italic>in vitro</italic> during the drug development phases and was accompanied by the demonstration of reduced viral fitness of resistant variants (<xref rid="CIT0026" ref-type="bibr">26</xref>–<xref rid="CIT0028" ref-type="bibr">28</xref>). NAI treatment of IAV-infected humans may also generate resistant viruses and is primarily described following treatment with oseltamivir and occurs both in human (<xref rid="CIT0029" ref-type="bibr">29</xref>–<xref rid="CIT0031" ref-type="bibr">31</xref>) and avian viruses (<xref rid="CIT0022" ref-type="bibr">22</xref>, <xref rid="CIT0032" ref-type="bibr">32</xref>, <xref rid="CIT0033" ref-type="bibr">33</xref>). Clinically, resistance to NAIs is associated with prolonged infections in children and in immunosuppressed patients (<xref rid="CIT0029" ref-type="bibr">29</xref>, <xref rid="CIT0034" ref-type="bibr">34</xref>); and in A(H7N9) and HPAI A(H5N1) cases with high viral loads and severe clinical outcomes (<xref rid="CIT0032" ref-type="bibr">32</xref>, <xref rid="CIT0033" ref-type="bibr">33</xref>). Following market introduction, the overall OC resistance in clinical settings was reported to be less than 1% in adults and 4% in children under 12 years of age but higher in hospitalized children, immunocompromised individuals, and in HPAI A(H5N1) infected patients (<xref rid="CIT0022" ref-type="bibr">22</xref>). Although much less common than OC resistance (<xref rid="CIT0035" ref-type="bibr">35</xref>), ZA resistance in ZA treated patients has also been described (<xref rid="CIT0022" ref-type="bibr">22</xref>, <xref rid="CIT0036" ref-type="bibr">36</xref>).</p><p>However, raising more concern than selection for resistant variants by clinical treatment is the circulation of NAI-resistant human strains in the absence of selective drug pressure. This feature was primarily described in the seasonal A(H1N1) virus 2007–2009 when the circulating strain was OC resistant due to an H274Y substitution in NA, without selective drug exposure (<xref rid="CIT0037" ref-type="bibr">37</xref>). In 2009, the resistant seasonal A(H1N1) virus was entirely replaced by the NAI-susceptible (though adamantane-resistant) pandemic A(H1N1)/pdm09 virus. However, since 2010/2011, an increasing number of community cases with OC-resistant A(H1N1)/pdm09 viruses have been reported without previous oseltamivir exposure; in nearly all instances the resistance has been conferred by the H274Y substitution in NA (<xref rid="CIT0038" ref-type="bibr">38</xref>–<xref rid="CIT0041" ref-type="bibr">41</xref>).</p><p>Avian IAVs of wild waterfowl have been tested for NAI susceptibility only to a very limited extent compared to human viruses, especially regarding subtypes other than those infecting humans (<xref rid="CIT0042" ref-type="bibr">42</xref>). Two screening studies on avian N1 and N6 subtypes, each containing fewer than 100 samples mainly collected from North America between 1976 and 2010, as well as a European study with 21 samples collected between 2002 and 2005, did not detect naturally occurring high-level resistance among wild bird avian IAVs (<xref rid="CIT0042" ref-type="bibr">42</xref>–<xref rid="CIT0044" ref-type="bibr">44</xref>).</p></sec><sec id="S0003"><title>Environmental pollution with NAIs</title><p>After administration of both oseltamivir and ZA, 75–80% of the active OC and ZA are excreted by urine or feces (<xref rid="CIT0019" ref-type="bibr">19</xref>, <xref rid="CIT0045" ref-type="bibr">45</xref>). Both components are poorly removed by conventional sewage treatment and therefore end up in aquatic environments (<xref rid="CIT0046" ref-type="bibr">46</xref>, <xref rid="CIT0047" ref-type="bibr">47</xref>). OC is the most studied substance, both regarding drug measurements in aquatic environments and regarding experimental studies on degradation and removal of the metabolite from water.</p><p>There is a correlation between the amount of oseltamivir that is prescribed to patients and the OC concentrations detected in effluents of sewage treatment plants (STPs) and in river water, with higher drug concentrations in STP effluents (<xref rid="CIT0048" ref-type="bibr">48</xref>–<xref rid="CIT0053" ref-type="bibr">53</xref>). It is however the presence of active drugs in aquatic environments that can be expected to have an ecological effect.</p><p>In Japan, which accounts for over 70% of the global oseltamivir prescription (<xref rid="CIT0054" ref-type="bibr">54</xref>, <xref rid="CIT0055" ref-type="bibr">55</xref>), numerous environmental measurements over the last 5–10 years have detected OC in river water in the range of a few 100 ng/L up to 865 ng/L (<xref rid="CIT0048" ref-type="bibr">48</xref>, <xref rid="CIT0051" ref-type="bibr">51</xref>, <xref rid="CIT0056" ref-type="bibr">56</xref>–<xref rid="CIT0060" ref-type="bibr">60</xref>). Studies in a number of European countries have detected OC in river water at average concentrations of approximately 50 ng/L, with a range up to 200 ng/L (<xref rid="CIT0049" ref-type="bibr">49</xref>, <xref rid="CIT0050" ref-type="bibr">50</xref>, <xref rid="CIT0052" ref-type="bibr">52</xref>, <xref rid="CIT0061" ref-type="bibr">61</xref>, <xref rid="CIT0062" ref-type="bibr">62</xref>). Samples from the Rhine River at the border between Germany, France, and Switzerland, contained high concentrations of non-metabolized OP relative to OC (OP/OC ratio 13.1 as compared to <1 in STP effluents), indicating release from drug manufacturing (in Switzerland) in addition to sewage discharge (<xref rid="CIT0052" ref-type="bibr">52</xref>).</p><p>The lower use of ZA, peramivir, and laninamivir as compared to OC is reflected in lower levels of active drugs released to aquatic environments. In Japan, drug concentrations of up to 59 ng/L of ZA, 11 ng/L of peramivir, and 9 ng/L of laninamivir have been measured in river water, with dynamics that are correlated with the number of influenza cases during the influenza season (<xref rid="CIT0053" ref-type="bibr">53</xref>, <xref rid="CIT0058" ref-type="bibr">58</xref>, <xref rid="CIT0060" ref-type="bibr">60</xref>).</p><p>Environmental risk assessment of NAIs in aquatic systems includes evaluation of eco-toxicological effects and of direct antiviral effects on naturally circulating IAVs, including the potential for resistance development. There is a lack of knowledge regarding the eco-toxicological effects by OC, and prediction studies by mathematical modeling have led to varying conclusions regarding toxic effects on algae and fish (<xref rid="CIT0063" ref-type="bibr">63</xref>–<xref rid="CIT0066" ref-type="bibr">66</xref>).</p></sec><sec id="S0004"><title>Removal of oseltamivir by sewage water treatment</title><p>Conventional STPs use different techniques to remove waste products, usually a combination of mechanical treatment followed by chemical and biological (active sludge) treatment (<xref rid="CIT0046" ref-type="bibr">46</xref>, <xref rid="CIT0052" ref-type="bibr">52</xref>, <xref rid="CIT0059" ref-type="bibr">59</xref>). Measurements of pharmaceuticals from influents and effluents of conventional STPs have demonstrated between 0% (<xref rid="CIT0049" ref-type="bibr">49</xref>, <xref rid="CIT0059" ref-type="bibr">59</xref>) and 59% OC removal by the treatment (<xref rid="CIT0052" ref-type="bibr">52</xref>). Experimental studies have demonstrated that OC is not removed by conventional sewage treatment (<xref rid="CIT0046" ref-type="bibr">46</xref>) nor degraded by UV light exposure (<xref rid="CIT0046" ref-type="bibr">46</xref>, <xref rid="CIT0067" ref-type="bibr">67</xref>), which often is an important degradation mechanism of drug metabolites in the environment (<xref rid="CIT0068" ref-type="bibr">68</xref>).</p><p>In studies investigating other potential degradation methods, bacterial strains able to degrade and use OC as their sole carbon and energy source (a <italic>Nocardioides</italic> sp. and a <italic>Flavobacterium</italic> sp.) were isolated from environmental water sediments, suggesting biological degradation pathways of OC (<xref rid="CIT0069" ref-type="bibr">69</xref>). Accordingly, in several degradation studies in water, microbial processes were demonstrated to be important for the dissipation of OC from waste water. OC removal can be increased by addition of active microbial sludge (<xref rid="CIT0070" ref-type="bibr">70</xref>, <xref rid="CIT0071" ref-type="bibr">71</xref>), active sediments from natural waters (<xref rid="CIT0069" ref-type="bibr">69</xref>, <xref rid="CIT0072" ref-type="bibr">72</xref>), and by fungal (<italic>Phanerochaete chrysosporium</italic>) exposure (<xref rid="CIT0073" ref-type="bibr">73</xref>). The results of biodegradation studies have led to suggestions for bioremediation approaches in sewage treatment (<xref rid="CIT0069" ref-type="bibr">69</xref>, <xref rid="CIT0072" ref-type="bibr">72</xref>), though their efficiency might be questioned if the OC load were very high, that is in a pandemic situation (<xref rid="CIT0071" ref-type="bibr">71</xref>).</p><p>Adding ozone treatment to the conventional methods of wastewater treatment has proven very efficient in removing OC and other NAIs experimentally (<xref rid="CIT0053" ref-type="bibr">53</xref>, <xref rid="CIT0074" ref-type="bibr">74</xref>). Confirming the experimental data, drug measurements from STP influents and effluents at units that use ozone treatment in addition to conventional techniques have repeatedly demonstrated significantly lower concentrations of released drugs as compared to conventional STPs. Over 85% of all NAIs are removed by adding a tertiary sewage treatment with ozone (<xref rid="CIT0051" ref-type="bibr">51</xref>, <xref rid="CIT0053" ref-type="bibr">53</xref>, <xref rid="CIT0059" ref-type="bibr">59</xref>, <xref rid="CIT0060" ref-type="bibr">60</xref>, <xref rid="CIT0075" ref-type="bibr">75</xref>).</p></sec><sec id="S0005"><title>Influenza A in the natural hosts</title><p>The natural reservoir host of IAV is wild waterfowl, primarily Charadriiformes (in particular gulls, terns, and waders) and Anseriformes (in particular ducks, geese, and swans) (<xref rid="CIT0002" ref-type="bibr">2</xref>, <xref rid="CIT0003" ref-type="bibr">3</xref>). Most subtype combinations of the 16 hemagglutinin (HA) and 9 NA surface proteins can be detected in wild waterfowl. Despite more pronounced subtype diversity among shorebird viruses, viral prevalence is highest in dabbling ducks (<xref rid="CIT0076" ref-type="bibr">76</xref>, <xref rid="CIT0077" ref-type="bibr">77</xref>), among which the mallard (<italic>Anas platyrhynchos</italic>) is considered to be the most common IAV host species (<xref rid="CIT0078" ref-type="bibr">78</xref>). During the autumn migration of birds in the Northern Hemisphere, the IAV prevalence typically peaks in dabbling ducks at up to 60% compared to 0.4–2% at wintering grounds (<xref rid="CIT0002" ref-type="bibr">2</xref>, <xref rid="CIT0003" ref-type="bibr">3</xref>, <xref rid="CIT0079" ref-type="bibr">79</xref>). On the contrary, in the Delaware Bay on the North American east coast IAV prevalence is exceptionally high in shorebirds during the spring migration with over 10% prevalence, which is much higher than elsewhere and coincides with the congregation of waders and gulls foraging for horseshoe crab eggs (<xref rid="CIT0003" ref-type="bibr">3</xref>, <xref rid="CIT0076" ref-type="bibr">76</xref>, <xref rid="CIT0077" ref-type="bibr">77</xref>, <xref rid="CIT0080" ref-type="bibr">80</xref>, <xref rid="CIT0081" ref-type="bibr">81</xref>).</p><p>In wild waterfowl IAVs cause an intestinal tract infection, and although large amounts of virus are shed in feces the infection is relatively asymptomatic (<xref rid="CIT0002" ref-type="bibr">2</xref>, <xref rid="CIT0082" ref-type="bibr">82</xref>, <xref rid="CIT0083" ref-type="bibr">83</xref>). The temporal and spatial dynamics, as well as the evolution of IAVs in the natural hosts, are closely related to the ecology, immunology, and migration of the birds (<xref rid="CIT0003" ref-type="bibr">3</xref>). As dabbling ducks switch breeding grounds between years, there are opportunities for viral transmission to different subpopulations over wide geographical areas (<xref rid="CIT0003" ref-type="bibr">3</xref>, <xref rid="CIT0078" ref-type="bibr">78</xref>, <xref rid="CIT0084" ref-type="bibr">84</xref>). Perpetuation of low pathogenic avian influenza (LPAI) viruses in wild waterfowl year round is suggested to be a combination of 1) continuous transmission to juvenile and non-immune ducks at breeding and pre-migration congregation areas; 2) spread of virus with migrating birds; and 3) low prevalence circulation in resident ducks during the winter season in temperate locations (<xref rid="CIT0002" ref-type="bibr">2</xref>, <xref rid="CIT0085" ref-type="bibr">85</xref>, <xref rid="CIT0086" ref-type="bibr">86</xref>). In addition, IAVs are known to stay infectious for a long time in lake water (<xref rid="CIT0002" ref-type="bibr">2</xref>); freezing of viruses in lakes at breeding areas with reinfection of birds the following season is suggested to be another mechanism for viral perpetuation (<xref rid="CIT0078" ref-type="bibr">78</xref>).</p><p>The genetic variability of wild waterfowl viruses is much greater than that of IAVs in other hosts, including combinations of most HAs and NAs without persisting sublineages (<xref rid="CIT0002" ref-type="bibr">2</xref>) and a high diversity between HA and NA subtypes as well as of the nonstructural (NS) gene (<xref rid="CIT0087" ref-type="bibr">87</xref>, <xref rid="CIT0088" ref-type="bibr">88</xref>). There is a continuous emergence of new viral variants, achieved both by frequent point mutations (genetic drift) (<xref rid="CIT0089" ref-type="bibr">89</xref>, <xref rid="CIT0090" ref-type="bibr">90</xref>) and, typical for the segmented IAV genome, by re-assortment events (genetic shift), which occur at a high frequency as a result of very common coinfections with more than one IAV in wild waterfowl (<xref rid="CIT0086" ref-type="bibr">86</xref>, <xref rid="CIT0087" ref-type="bibr">87</xref>, <xref rid="CIT0091" ref-type="bibr">91</xref>).</p></sec><sec id="S0006"><title>Risk for resistant IAV of wild waterfowl</title><p>Despite the fact that natural IAV hosts reside in aquatic environments potentially polluted by NAIs, resistance screening of avian IAVs carried by wild waterfowl has to date been limited, as discussed above. Experimental <italic>in vivo</italic> systems testing the hypothesis that OC exposure of IAV-infected natural host birds leads to resistance development have confirmed that avian IAVs containing both Group 1 and Group 2 NAs become resistant when infected mallards are exposed to OC in their water (<xref rid="CIT0092" ref-type="bibr">92</xref>–<xref rid="CIT0095" ref-type="bibr">95</xref>). When mallards experimentally infected with an avian A(H1N1) virus were exposed to 0.95 µg/L of OC in their water, OC resistance conferred by the H274Y substitution in NA evolved. Despite the H274Y resistance substitution, leading to highly reduced OC susceptibility, infectivity and transmissibility between mallards was maintained (<xref rid="CIT0092" ref-type="bibr">92</xref>). In a subsequent study in the same experimental model with the resistant A(H1N1)/H274Y variant in which drug exposure was removed from infected mallards, the resistant variant persisted without drug pressure (<xref rid="CIT0096" ref-type="bibr">96</xref>). Maintenance of a resistant genotype and phenotype without selective drug pressure suggests a maintained viral fitness as compared to wild-type virus. In the same <italic>in vivo</italic> mallard model an A(H6N2) virus acquired high-level OC resistance conferred by the R292K substitution when ducks were exposed to 12 µg/L of OC (<xref rid="CIT0094" ref-type="bibr">94</xref>), while a low pathogenic A(H7N9) virus acquired the resistance-related I222T framework substitution at 2.5 µg/L of OC exposure (<xref rid="CIT0095" ref-type="bibr">95</xref>). Infectivity and transmissibility between mallards was maintained during drug pressure by both of the viruses, but when the resistant A(H6N2)/R292K variant was allowed to replicate in mallards without drug pressure it reverted to wild type, confirming a reduced viral fitness of the resistant variant (<xref rid="CIT0097" ref-type="bibr">97</xref>). In another <italic>in vivo</italic> mallard model, selection for the framework NA substitution E119V in a low pathogenic A(H5N2) virus was demonstrated when infected ducks were exposed to 1 µg/L of OC in water. The resistant A(H5N2)/E119V variant dominated the viral population and was transmissible between mallards, but it was outcompeted by wild-type virus when drug exposure was removed (<xref rid="CIT0093" ref-type="bibr">93</xref>).</p><p>The available results from experimental OC exposure studies of avian IAVs demonstrate that both Group 1 and Group 2 viruses may acquire resistance if the natural host birds are exposed to low levels of OC in their water. The propensity to maintain the acquired resistance without drug pressure varies between NA groups, subtypes, and strains. The different propensity is influenced by the subtype-specific resistance substitutions, as a framework substitution like H274Y may be compensated for more easily without compromising viral fitness than an active site residue, like R292K. Clearly, the exact genetic context in which a resistance mutation is induced is paramount for the potential of its persistence without drug pressure and for the potential of the resistant viral variant to circulate among wild birds.</p><p>In human IAVs, resistance to OC occurs in clinical settings both in A(H3N2) and in A(H1N1) viruses (<xref rid="CIT0022" ref-type="bibr">22</xref>), but thus far only resistant A(H1N1) strains have circulated in the community without drug pressure. The dependence on the genetic context in which a resistance mutation is acquired is demonstrated by the permissive mutations compensating for reduced viral fitness. Different permissive mutations have been identified for OC-resistant human A(H1N1) viruses in which the resistance is conferred by the H274Y substitution, including the seasonal virus in 2007–2009 (<xref rid="CIT0037" ref-type="bibr">37</xref>, <xref rid="CIT0098" ref-type="bibr">98</xref>, <xref rid="CIT0099" ref-type="bibr">99</xref>) and OC-resistant A(H1N1)/2009pdm/H274Y community clusters in Australia and Japan (<xref rid="CIT0040" ref-type="bibr">40</xref>, <xref rid="CIT0041" ref-type="bibr">41</xref>, <xref rid="CIT0100" ref-type="bibr">100</xref>).</p><p>In the experimental OC-exposure mallard studies, the drug concentrations at which resistant variants emerged varied between studies. In the environment, numerous measurements of OC in the main river systems in Japan have confirmed concentrations up to 0.86 µg/L (<xref rid="CIT0057" ref-type="bibr">57</xref>), while European studies at several river sites have detected OC in the range of 0.02–0.2 µg/L (<xref rid="CIT0050" ref-type="bibr">50</xref>, <xref rid="CIT0052" ref-type="bibr">52</xref>, <xref rid="CIT0062" ref-type="bibr">62</xref>). The drug concentrations at which avian IAVs experimentally developed resistance in mallards were thus above the environmental ones detected to date. However, they are in the same magnitude, and as the OC levels in river water vary with oseltamivir consumption (<xref rid="CIT0048" ref-type="bibr">48</xref>, <xref rid="CIT0061" ref-type="bibr">61</xref>) and with the quality of sewage treatment (<xref rid="CIT0051" ref-type="bibr">51</xref>) higher environmental concentrations may occasionally occur. Although the exposure of aquatic birds may be lower at STP effluents, it should be noted that OC concentrations in these locations are multiples higher than in river water (<xref rid="CIT0048" ref-type="bibr">48</xref>, <xref rid="CIT0049" ref-type="bibr">49</xref>, <xref rid="CIT0051" ref-type="bibr">51</xref>).</p><p>As IAVs acquire resistance mutations at various drug concentrations, predictions on the amount of pharmaceuticals in the environment that constitute a risk for resistance induction are uncertain. The high genetic variability of avian IAVs (<xref rid="CIT0087" ref-type="bibr">87</xref>) provides the opportunity for genetic contexts to be permissive if selective pressure for resistance occurs. The experimental results from OC exposure studies over the last couple of years (<xref rid="CIT0092" ref-type="bibr">92</xref>–<xref rid="CIT0097" ref-type="bibr">97</xref>) have contributed to the estimations of the ecologic risks related to the release of active NAIs to the environment. The results indicate that there is a risk for the evolution of resistant avian IAVs in the natural host birds.</p><p>Knowledge on the levels of OC released to aquatic environments (<xref rid="CIT0050" ref-type="bibr">50</xref>, <xref rid="CIT0057" ref-type="bibr">57</xref>), combined with the observations of IAV resistance development in experimentally exposed host birds, warrants broad implementation of new efficient sewage water treatment techniques (<xref rid="CIT0059" ref-type="bibr">59</xref>) and rational use of available NAIs.</p><p>It remains an area of research whether an OC-resistant waterfowl-adapted IAV may maintain a resistance trait through the complex evolutionary process to a new resistant human pathogenic virus. If such a virus were to emerge and be highly pathogenic to humans, the current stockpiles of oseltamivir would be of no use and the public health impact of a pandemic would be substantially worsened. Other future areas of research include increased OC resistance screening of avian IAVs of wild waterfowl, both regarding the number of tested samples and geographic regions, as well as the evaluation of the potential for resistance development to other NAIs in natural host birds. A number of new anti-influenza drugs are expected to be introduced to the market within the coming years (<xref rid="CIT0013" ref-type="bibr">13</xref>). The development of new influenza drugs needs to include studies on their ecologic and environmental impact, including their potential to generate resistant IAVs in wild birds.</p></sec></body><back><sec sec-type="COI-statement"><title>Conflict of interest and funding</title><p>The author has received financial support from the Swedish Research Council FORMAS and from the Family Olinder-Nielsen's Foundation.</p></sec><ref-list><title>References</title><ref id="CIT0001"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fields</surname><given-names>BN</given-names></name><name><surname>Knipe</surname><given-names>DM</given-names></name><name><surname>Howley</surname><given-names>PM</given-names></name></person-group><source>Fields’ virology</source><year>2007</year><edition>5th ed</edition><publisher-loc>Philadelphia, PA</publisher-loc><publisher-name>Lippincott Williams & Wilkins</publisher-name></element-citation></ref><ref id="CIT0002"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webster</surname><given-names>RG</given-names></name><name><surname>Bean</surname><given-names>WJ</given-names></name><name><surname>Gorman</surname><given-names>OT</given-names></name><name><surname>Chambers</surname><given-names>TM</given-names></name><name><surname>Kawaoka</surname><given-names>Y</given-names></name></person-group><article-title>Evolution and ecology of influenza A viruses</article-title><source>Microbiol Rev</source><year>1992</year><volume>56</volume><fpage>152</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">1579108</pub-id></element-citation></ref><ref id="CIT0003"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>B</given-names></name><name><surname>Munster</surname><given-names>VJ</given-names></name><name><surname>Wallensten</surname><given-names>A</given-names></name><name><surname>Waldenström</surname><given-names>J</given-names></name><name><surname>Osterhaus</surname><given-names>AD</given-names></name><name><surname>Fouchier</surname><given-names>RA</given-names></name></person-group><article-title>Global patterns of influenza A virus in wild birds</article-title><source>Science</source><year>2006</year><volume>312</volume><fpage>384</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16627734</pub-id></element-citation></ref><ref id="CIT0004"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brockwell-Staats</surname><given-names>C</given-names></name><name><surname>Webster</surname><given-names>RG</given-names></name><name><surname>Webby</surname><given-names>RJ</given-names></name></person-group><article-title>Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A (H1N1)</article-title><source>Influenza Other Respir Viruses</source><year>2009</year><volume>3</volume><fpage>207</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">19768134</pub-id></element-citation></ref><ref id="CIT0005"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>NJ</given-names></name><name><surname>Subbarao</surname><given-names>K</given-names></name></person-group><article-title>Global epidemiology of influenza: past and present</article-title><source>Annu Rev Med</source><year>2000</year><volume>51</volume><fpage>407</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">10774473</pub-id></element-citation></ref><ref id="CIT0006"><label>6</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Monto</surname><given-names>AS</given-names></name><name><surname>Webster</surname><given-names>RG</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Webster</surname><given-names>RG</given-names></name><name><surname>Monto</surname><given-names>AS</given-names></name><name><surname>Braciale</surname><given-names>TJ</given-names></name><name><surname>Lamb</surname><given-names>RA</given-names></name></person-group><article-title>Influenza pandemics: history and lessons learned</article-title><source>Textbook of influenza</source><year>2013</year><edition>2nd ed</edition><publisher-loc>Oxford, UK</publisher-loc><publisher-name>Wiley</publisher-name><fpage>20</fpage><lpage>34</lpage></element-citation></ref><ref id="CIT0007"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>To</surname><given-names>KK</given-names></name><name><surname>Chan</surname><given-names>JF</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Yuen</surname><given-names>KY</given-names></name></person-group><article-title>The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities</article-title><source>Lancet Infect Dis</source><year>2013</year><volume>13</volume><fpage>809</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">23969217</pub-id></element-citation></ref><ref id="CIT0008"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel-Ghafar</surname><given-names>AN</given-names></name><name><surname>Chotpitayasunondh</surname><given-names>T</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Hayden</surname><given-names>FG</given-names></name><name><surname>Nguyen</surname><given-names>DH</given-names></name><name><surname>de Jong</surname><given-names>MD</given-names></name><etal></etal></person-group><article-title>Update on avian influenza A (H5N1) virus infection in humans</article-title><source>N Engl J Med</source><year>2008</year><volume>358</volume><fpage>261</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">18199865</pub-id></element-citation></ref><ref id="CIT0009"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanner</surname><given-names>WD</given-names></name><name><surname>Toth</surname><given-names>DJ</given-names></name><name><surname>Gundlapalli</surname><given-names>AV</given-names></name></person-group><article-title>The pandemic potential of avian influenza A(H7N9) virus: a review</article-title><source>Epidemiol Infect</source><year>2015</year><volume>143</volume><fpage>3359</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">26205078</pub-id></element-citation></ref><ref id="CIT0010"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiore</surname><given-names>AE</given-names></name><name><surname>Uyeki</surname><given-names>TM</given-names></name><name><surname>Broder</surname><given-names>K</given-names></name><name><surname>Finelli</surname><given-names>L</given-names></name><name><surname>Euler</surname><given-names>GL</given-names></name><name><surname>Singleton</surname><given-names>JA</given-names></name><etal></etal></person-group><article-title>Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010</article-title><source>MMWR Recomm Rep</source><year>2010</year><volume>59</volume><fpage>1</fpage><lpage>62</lpage></element-citation></ref><ref id="CIT0011"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Partridge</surname><given-names>J</given-names></name><name><surname>Kieny</surname><given-names>MP</given-names></name></person-group><article-title>Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009–2010 and comparison with previous estimates and global action plan targets</article-title><source>Vaccine</source><year>2010</year><volume>28</volume><fpage>4709</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">20488262</pub-id></element-citation></ref><ref id="CIT0012"><label>12</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nguyen-Van-Tam</surname><given-names>JS</given-names></name><name><surname>Bresee</surname><given-names>J</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Webster</surname><given-names>RG</given-names></name><name><surname>Monto</surname><given-names>AS</given-names></name><name><surname>Braciale</surname><given-names>TJ</given-names></name><name><surname>Lamb</surname><given-names>RA</given-names></name></person-group><article-title>Pandemic preparedness and response</article-title><source>Textbook of influenza</source><year>2013</year><edition>2nd ed</edition><publisher-loc>Oxford, UK</publisher-loc><publisher-name>Wiley</publisher-name><fpage>453</fpage><lpage>69</lpage></element-citation></ref><ref id="CIT0013"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webster</surname><given-names>RG</given-names></name><name><surname>Govorkova</surname><given-names>EA</given-names></name></person-group><article-title>Continuing challenges in influenza</article-title><source>Ann N Y Acad Sci</source><year>2014</year><volume>1323</volume><fpage>115</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">24891213</pub-id></element-citation></ref><ref id="CIT0014"><label>14</label><element-citation publication-type="journal"><collab>WHO</collab><article-title>Meetings of the WHO working group on surveillance of influenza antiviral susceptibility – Geneva, November 2011 and June 2012</article-title><source>Wkly Epidemiol Rec</source><year>2012</year><volume>87</volume><fpage>369</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">23061103</pub-id></element-citation></ref><ref id="CIT0015"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurt</surname><given-names>AC</given-names></name><name><surname>Besselaar</surname><given-names>TG</given-names></name><name><surname>Daniels</surname><given-names>RS</given-names></name><name><surname>Ermetal</surname><given-names>B</given-names></name><name><surname>Fry</surname><given-names>A</given-names></name><name><surname>Gubareva</surname><given-names>L</given-names></name><etal></etal></person-group><article-title>Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015</article-title><source>Antiviral Res</source><year>2016</year><volume>132</volume><fpage>178</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">27265623</pub-id></element-citation></ref><ref id="CIT0016"><label>16</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ison</surname><given-names>MG</given-names></name><name><surname>Hay</surname><given-names>A</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Webster</surname><given-names>RG</given-names></name><name><surname>Monto</surname><given-names>AS</given-names></name><name><surname>Braciale</surname><given-names>TJ</given-names></name><name><surname>Lamb</surname><given-names>RA</given-names></name></person-group><article-title>Antivirals: targets and use</article-title><source>Textbook of influenza</source><year>2013</year><edition>2nd ed</edition><publisher-loc>Oxford, UK</publisher-loc><publisher-name>Wiley</publisher-name><fpage>392</fpage><lpage>418</lpage></element-citation></ref><ref id="CIT0017"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>A</given-names></name><name><surname>Gorman</surname><given-names>SE</given-names></name></person-group><article-title>Stockpiling antiviral drugs for the next influenza pandemic</article-title><source>Clin Pharmacol Ther</source><year>2009</year><volume>86</volume><fpage>241</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">19707215</pub-id></element-citation></ref><ref id="CIT0018"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan Po</surname><given-names>AL</given-names></name><name><surname>Farndon</surname><given-names>P</given-names></name><name><surname>Palmer</surname><given-names>N</given-names></name></person-group><article-title>Maximizing the value of drug stockpiles for pandemic influenza</article-title><source>Emerg Infect Dis</source><year>2009</year><volume>15</volume><fpage>1686</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">19861076</pub-id></element-citation></ref><ref id="CIT0019"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>JR</given-names></name><name><surname>Rayner</surname><given-names>CR</given-names></name><name><surname>Donner</surname><given-names>B</given-names></name><name><surname>Wollenhaupt</surname><given-names>M</given-names></name><name><surname>Klumpp</surname><given-names>K</given-names></name><name><surname>Dutkowski</surname><given-names>R</given-names></name></person-group><article-title>Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience</article-title><source>Adv Ther</source><year>2011</year><volume>28</volume><fpage>927</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">22057727</pub-id></element-citation></ref><ref id="CIT0020"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>RJ</given-names></name><name><surname>Haire</surname><given-names>LF</given-names></name><name><surname>Stevens</surname><given-names>DJ</given-names></name><name><surname>Collins</surname><given-names>PJ</given-names></name><name><surname>Lin</surname><given-names>YP</given-names></name><name><surname>Blackburn</surname><given-names>GM</given-names></name><etal></etal></person-group><article-title>The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design</article-title><source>Nature</source><year>2006</year><volume>443</volume><fpage>45</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16915235</pub-id></element-citation></ref><ref id="CIT0021"><label>21</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Russel</surname><given-names>RJ</given-names></name><name><surname>Gamblin</surname><given-names>SJ</given-names></name><name><surname>Skehel</surname><given-names>JJ</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Webster</surname><given-names>RG</given-names></name><name><surname>Monto</surname><given-names>AS</given-names></name><name><surname>Braciale</surname><given-names>TJ</given-names></name><name><surname>Lamb</surname><given-names>RA</given-names></name></person-group><article-title>Influenza glycoproteins: hemagglutinin and neuraminidase</article-title><source>Textbook of influenza</source><year>2013</year><edition>2nd ed</edition><publisher-loc>Oxford, UK</publisher-loc><publisher-name>Wiley</publisher-name><fpage>67</fpage><lpage>100</lpage></element-citation></ref><ref id="CIT0022"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samson</surname><given-names>M</given-names></name><name><surname>Pizzorno</surname><given-names>A</given-names></name><name><surname>Abed</surname><given-names>Y</given-names></name><name><surname>Boivin</surname><given-names>G</given-names></name></person-group><article-title>Influenza virus resistance to neuraminidase inhibitors</article-title><source>Antiviral Res</source><year>2013</year><volume>98</volume><fpage>174</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">23523943</pub-id></element-citation></ref><ref id="CIT0023"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKimm-Breschkin</surname><given-names>JL</given-names></name></person-group><article-title>Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance</article-title><source>Influenza Other Respir Viruses</source><year>2013</year><volume>7</volume><issue>Suppl 1</issue><fpage>25</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">23279894</pub-id></element-citation></ref><ref id="CIT0024"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colman</surname><given-names>PM</given-names></name><name><surname>Hoyne</surname><given-names>PA</given-names></name><name><surname>Lawrence</surname><given-names>MC</given-names></name></person-group><article-title>Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase</article-title><source>J Virol</source><year>1993</year><volume>67</volume><fpage>2972</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">8497041</pub-id></element-citation></ref><ref id="CIT0025"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferraris</surname><given-names>O</given-names></name><name><surname>Lina</surname><given-names>B</given-names></name></person-group><article-title>Mutations of neuraminidase implicated in neuraminidase inhibitors resistance</article-title><source>J Clin Virol</source><year>2008</year><volume>41</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">18055254</pub-id></element-citation></ref><ref id="CIT0026"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>CY</given-names></name><name><surname>Escarpe</surname><given-names>PA</given-names></name><name><surname>Sidwell</surname><given-names>RW</given-names></name><name><surname>Williams</surname><given-names>MA</given-names></name><name><surname>Lew</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071</article-title><source>Antimicrob Agents Chemother</source><year>1998</year><volume>42</volume><fpage>3234</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">9835519</pub-id></element-citation></ref><ref id="CIT0027"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gubareva</surname><given-names>LV</given-names></name><name><surname>Robinson</surname><given-names>MJ</given-names></name><name><surname>Bethell</surname><given-names>RC</given-names></name><name><surname>Webster</surname><given-names>RG</given-names></name></person-group><article-title>Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en</article-title><source>J Virol</source><year>1997</year><volume>71</volume><fpage>3385</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">9094607</pub-id></element-citation></ref><ref id="CIT0028"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKimm-Breschkin</surname><given-names>JL</given-names></name><name><surname>Sahasrabudhe</surname><given-names>A</given-names></name><name><surname>Blick</surname><given-names>TJ</given-names></name><name><surname>McDonald</surname><given-names>M</given-names></name><name><surname>Colman</surname><given-names>PM</given-names></name><name><surname>Hart</surname><given-names>GJ</given-names></name><etal></etal></person-group><article-title>Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors</article-title><source>J Virol</source><year>1998</year><volume>72</volume><fpage>2456</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">9499107</pub-id></element-citation></ref><ref id="CIT0029"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiso</surname><given-names>M</given-names></name><name><surname>Mitamura</surname><given-names>K</given-names></name><name><surname>Sakai-Tagawa</surname><given-names>Y</given-names></name><name><surname>Shiraishi</surname><given-names>K</given-names></name><name><surname>Kawakami</surname><given-names>C</given-names></name><name><surname>Kimura</surname><given-names>K</given-names></name><etal></etal></person-group><article-title>Resistant influenza A viruses in children treated with oseltamivir: descriptive study</article-title><source>Lancet</source><year>2004</year><volume>364</volume><fpage>759</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">15337401</pub-id></element-citation></ref><ref id="CIT0030"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitley</surname><given-names>RJ</given-names></name><name><surname>Boucher</surname><given-names>CA</given-names></name><name><surname>Lina</surname><given-names>B</given-names></name><name><surname>Nguyen-Van-Tam</surname><given-names>JS</given-names></name><name><surname>Osterhaus</surname><given-names>A</given-names></name><name><surname>Schutten</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Global assessment of resistance to neuraminidase inhibitors, 2008–2011: the Influenza Resistance Information Study (IRIS)</article-title><source>Clin Infect Dis</source><year>2013</year><volume>56</volume><fpage>1197</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">23307766</pub-id></element-citation></ref><ref id="CIT0031"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gubareva</surname><given-names>LV</given-names></name><name><surname>Kaiser</surname><given-names>L</given-names></name><name><surname>Matrosovich</surname><given-names>MN</given-names></name><name><surname>Soo-Hoo</surname><given-names>Y</given-names></name><name><surname>Hayden</surname><given-names>FG</given-names></name></person-group><article-title>Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir</article-title><source>J Infect Dis</source><year>2001</year><volume>183</volume><fpage>523</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">11170976</pub-id></element-citation></ref><ref id="CIT0032"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Jong</surname><given-names>MD</given-names></name><name><surname>Tran</surname><given-names>TT</given-names></name><name><surname>Truong</surname><given-names>HK</given-names></name><name><surname>Vo</surname><given-names>MH</given-names></name><name><surname>Smith</surname><given-names>GJ</given-names></name><name><surname>Nguyen</surname><given-names>VC</given-names></name><etal></etal></person-group><article-title>Oseltamivir resistance during treatment of influenza A (H5N1) infection</article-title><source>N Engl J Med</source><year>2005</year><volume>353</volume><fpage>2667</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">16371632</pub-id></element-citation></ref><ref id="CIT0033"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Song</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Hao</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance</article-title><source>Lancet</source><year>2013</year><volume>381</volume><fpage>2273</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">23726392</pub-id></element-citation></ref><ref id="CIT0034"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eshaghi</surname><given-names>A</given-names></name><name><surname>Shalhoub</surname><given-names>S</given-names></name><name><surname>Rosenfeld</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Higgins</surname><given-names>RR</given-names></name><name><surname>Stogios</surname><given-names>PJ</given-names></name><etal></etal></person-group><article-title>Multiple influenza A (H3N2) mutations conferring resistance to neuraminidase inhibitors in a bone marrow transplant recipient</article-title><source>Antimicrob Agents Chemother</source><year>2014</year><volume>58</volume><fpage>7188</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">25246391</pub-id></element-citation></ref><ref id="CIT0035"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorlund</surname><given-names>K</given-names></name><name><surname>Awad</surname><given-names>T</given-names></name><name><surname>Boivin</surname><given-names>G</given-names></name><name><surname>Thabane</surname><given-names>L</given-names></name></person-group><article-title>Systematic review of influenza resistance to the neuraminidase inhibitors</article-title><source>BMC Infect Dis</source><year>2011</year><volume>11</volume><fpage>134</fpage><pub-id pub-id-type="pmid">21592407</pub-id></element-citation></ref><ref id="CIT0036"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Vries</surname><given-names>E</given-names></name><name><surname>Stelma</surname><given-names>FF</given-names></name><name><surname>Boucher</surname><given-names>CA</given-names></name></person-group><article-title>Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus</article-title><source>N Engl J Med</source><year>2010</year><volume>363</volume><fpage>1381</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">20879894</pub-id></element-citation></ref><ref id="CIT0037"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moscona</surname><given-names>A</given-names></name></person-group><article-title>Global transmission of oseltamivir-resistant influenza</article-title><source>N Engl J Med</source><year>2009</year><volume>360</volume><fpage>953</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">19258250</pub-id></element-citation></ref><ref id="CIT0038"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storms</surname><given-names>AD</given-names></name><name><surname>Gubareva</surname><given-names>LV</given-names></name><name><surname>Su</surname><given-names>S</given-names></name><name><surname>Wheeling</surname><given-names>JT</given-names></name><name><surname>Okomo-Adhiambo</surname><given-names>M</given-names></name><name><surname>Pan</surname><given-names>CY</given-names></name><etal></etal></person-group><article-title>Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010–11</article-title><source>Emerg Infect Dis</source><year>2012</year><volume>18</volume><fpage>308</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">22305467</pub-id></element-citation></ref><ref id="CIT0039"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lackenby</surname><given-names>A</given-names></name><name><surname>Moran Gilad</surname><given-names>J</given-names></name><name><surname>Pebody</surname><given-names>R</given-names></name><name><surname>Miah</surname><given-names>S</given-names></name><name><surname>Calatayud</surname><given-names>L</given-names></name><name><surname>Bolotin</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11</article-title><source>Euro Surveill</source><year>2011</year><volume>16</volume><fpage>1</fpage><lpage>16</lpage></element-citation></ref><ref id="CIT0040"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takashita</surname><given-names>E</given-names></name><name><surname>Kiso</surname><given-names>M</given-names></name><name><surname>Fujisaki</surname><given-names>S</given-names></name><name><surname>Yokoyama</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Shirakura</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013–2014 influenza season in Japan</article-title><source>Antimicrob Agents Chemother</source><year>2015</year><volume>59</volume><fpage>2607</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">25691635</pub-id></element-citation></ref><ref id="CIT0041"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurt</surname><given-names>AC</given-names></name><name><surname>Hardie</surname><given-names>K</given-names></name><name><surname>Wilson</surname><given-names>NJ</given-names></name><name><surname>Deng</surname><given-names>YM</given-names></name><name><surname>Osbourn</surname><given-names>M</given-names></name><name><surname>Gehrig</surname><given-names>N</given-names></name><etal></etal></person-group><article-title>Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza</article-title><source>N Engl J Med</source><year>2011</year><volume>365</volume><fpage>2541</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">22204735</pub-id></element-citation></ref><ref id="CIT0042"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoner</surname><given-names>TD</given-names></name><name><surname>Krauss</surname><given-names>S</given-names></name><name><surname>Turner</surname><given-names>JC</given-names></name><name><surname>Seiler</surname><given-names>P</given-names></name><name><surname>Negovetich</surname><given-names>NJ</given-names></name><name><surname>Stallknecht</surname><given-names>DE</given-names></name><etal></etal></person-group><article-title>Susceptibility of avian influenza viruses of the N6 subtype to the neuraminidase inhibitor oseltamivir</article-title><source>Antiviral Res</source><year>2012</year><volume>93</volume><fpage>322</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">22252168</pub-id></element-citation></ref><ref id="CIT0043"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orozovic</surname><given-names>G</given-names></name><name><surname>Orozovic</surname><given-names>K</given-names></name><name><surname>Järhult</surname><given-names>JD</given-names></name><name><surname>Olsen</surname><given-names>B</given-names></name></person-group><article-title>Study of oseltamivir and zanamivir resistance-related mutations in influenza viruses isolated from wild mallards in Sweden</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e89306</fpage><pub-id pub-id-type="pmid">24558492</pub-id></element-citation></ref><ref id="CIT0044"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoner</surname><given-names>TD</given-names></name><name><surname>Krauss</surname><given-names>S</given-names></name><name><surname>DuBois</surname><given-names>RM</given-names></name><name><surname>Negovetich</surname><given-names>NJ</given-names></name><name><surname>Stallknecht</surname><given-names>DE</given-names></name><name><surname>Senne</surname><given-names>DA</given-names></name><etal></etal></person-group><article-title>Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype</article-title><source>J Virol</source><year>2010</year><volume>84</volume><fpage>9800</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">20660186</pub-id></element-citation></ref><ref id="CIT0045"><label>45</label><element-citation publication-type="book"><collab>LIFproduktresumé</collab><article-title>Produktresumé FASS Relenza</article-title><year>2015</year><publisher-loc>LIF</publisher-loc><publisher-name>Läkemedelsindustriföreningens Service AB</publisher-name><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.fass.se/LIF/product?userType=0&nplId=19990209000018&docType=3">http://www.fass.se/LIF/product?userType=0&nplId=19990209000018&docType=3</ext-link> [cited 18 January 2015]</comment></element-citation></ref><ref id="CIT0046"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fick</surname><given-names>J</given-names></name><name><surname>Lindberg</surname><given-names>RH</given-names></name><name><surname>Tysklind</surname><given-names>M</given-names></name><name><surname>Haemig</surname><given-names>PD</given-names></name><name><surname>Waldenström</surname><given-names>J</given-names></name><name><surname>Wallensten</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virus</article-title><source>PLoS One</source><year>2007</year><volume>2</volume><fpage>e986</fpage><pub-id pub-id-type="pmid">17912363</pub-id></element-citation></ref><ref id="CIT0047"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Vyas</surname><given-names>RK</given-names></name><name><surname>Pandit</surname><given-names>P</given-names></name><name><surname>Dalai</surname><given-names>AK</given-names></name></person-group><article-title>Occurrence and removal of antiviral drugs in environment: a review</article-title><source>Water Air Soil Pollut</source><year>2013</year><volume>224</volume><fpage>1</fpage><lpage>19</lpage></element-citation></ref><ref id="CIT0048"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azuma</surname><given-names>T</given-names></name><name><surname>Nakada</surname><given-names>N</given-names></name><name><surname>Yamashita</surname><given-names>N</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name></person-group><article-title>Synchronous dynamics of observed and predicted values of anti-influenza drugs in environmental waters during a seasonal influenza outbreak</article-title><source>Environ Sci Technol</source><year>2012</year><volume>46</volume><fpage>12873</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">23106220</pub-id></element-citation></ref><ref id="CIT0049"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leknes</surname><given-names>H</given-names></name><name><surname>Sturtzel</surname><given-names>IE</given-names></name><name><surname>Dye</surname><given-names>C</given-names></name></person-group><article-title>Environmental release of oseltamivir from a Norwegian sewage treatment plant during the 2009 influenza A (H1N1) pandemic</article-title><source>Sci Total Environ</source><year>2012</year><volume>414</volume><fpage>632</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">22127154</pub-id></element-citation></ref><ref id="CIT0050"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>AC</given-names></name><name><surname>Järhult</surname><given-names>JD</given-names></name><name><surname>Grabic</surname><given-names>R</given-names></name><name><surname>Khan</surname><given-names>GA</given-names></name><name><surname>Lindberg</surname><given-names>RH</given-names></name><name><surname>Fedorova</surname><given-names>G</given-names></name><etal></etal></person-group><article-title>Intra- and inter-pandemic variations of antiviral, antibiotics and decongestants in wastewater treatment plants and receiving rivers</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e108621</fpage><pub-id pub-id-type="pmid">25254643</pub-id></element-citation></ref><ref id="CIT0051"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>GC</given-names></name><name><surname>Nakada</surname><given-names>N</given-names></name><name><surname>Yamashita</surname><given-names>N</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name></person-group><article-title>Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan</article-title><source>Environ Health Perspect</source><year>2010</year><volume>118</volume><fpage>103</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">20056566</pub-id></element-citation></ref><ref id="CIT0052"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasse</surname><given-names>C</given-names></name><name><surname>Schlusener</surname><given-names>MP</given-names></name><name><surname>Schulz</surname><given-names>R</given-names></name><name><surname>Ternes</surname><given-names>TA</given-names></name></person-group><article-title>Antiviral drugs in wastewater and surface waters: a new pharmaceutical class of environmental relevance?</article-title><source>Environ Sci Technol</source><year>2010</year><volume>44</volume><fpage>1728</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">20108960</pub-id></element-citation></ref><ref id="CIT0053"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azuma</surname><given-names>T</given-names></name><name><surname>Ishiuchi</surname><given-names>H</given-names></name><name><surname>Inoyama</surname><given-names>T</given-names></name><name><surname>Teranishi</surname><given-names>Y</given-names></name><name><surname>Yamaoka</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><etal></etal></person-group><article-title>Detection of peramivir and laninamivir, new anti-influenza drugs, in sewage effluent and river waters in Japan</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e0131412</fpage><pub-id pub-id-type="pmid">26110817</pub-id></element-citation></ref><ref id="CIT0054"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tashiro</surname><given-names>M</given-names></name><name><surname>McKimm-Breschkin</surname><given-names>JL</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Klimov</surname><given-names>A</given-names></name><name><surname>Macken</surname><given-names>C</given-names></name><name><surname>Zambon</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996–2007</article-title><source>Antivir Ther</source><year>2009</year><volume>14</volume><fpage>751</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">19812437</pub-id></element-citation></ref><ref id="CIT0055"><label>55</label><element-citation publication-type="book"><collab>Hoffman-La-RocheINC</collab><article-title>Pediatric Advisory Committee Briefing Document for Tamiflu<sup>®</sup> (RO 64-0796) PAC Briefing Document</article-title><year>2007</year><publisher-loc>Nutley, New Jersey</publisher-loc><publisher-name>Hoffmann-La Roche Inc</publisher-name></element-citation></ref><ref id="CIT0056"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Söderström</surname><given-names>H</given-names></name><name><surname>Järhult</surname><given-names>JD</given-names></name><name><surname>Olsen</surname><given-names>B</given-names></name><name><surname>Lindberg</surname><given-names>RH</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Fick</surname><given-names>J</given-names></name></person-group><article-title>Detection of the antiviral drug oseltamivir in aquatic environments</article-title><source>PLoS One</source><year>2009</year><volume>4</volume><fpage>e6064</fpage><pub-id pub-id-type="pmid">19557131</pub-id></element-citation></ref><ref id="CIT0057"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takanami</surname><given-names>R</given-names></name><name><surname>Ozaki</surname><given-names>H</given-names></name><name><surname>Giri</surname><given-names>RR</given-names></name><name><surname>Taniguchi</surname><given-names>S</given-names></name><name><surname>Hayashi</surname><given-names>S</given-names></name></person-group><article-title>Detection of antiviral drugs oseltamivir phosphate and oseltamivir carboxylate in Neya River, Osaka Japan</article-title><source>J Water Environ Technol</source><year>2010</year><volume>8</volume><fpage>363</fpage><lpage>72</lpage></element-citation></ref><ref id="CIT0058"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takanami</surname><given-names>R</given-names></name><name><surname>Ozaki</surname><given-names>H</given-names></name><name><surname>Giri</surname><given-names>RR</given-names></name><name><surname>Taniguchi</surname><given-names>S</given-names></name><name><surname>Hayashi</surname><given-names>S</given-names></name></person-group><article-title>Antiviral drugs zanamivir and oseltamivir found in wastewater and surface water in Osaka, Japan</article-title><source>J Water Environ Technol</source><year>2012</year><volume>10</volume><fpage>57</fpage><lpage>68</lpage></element-citation></ref><ref id="CIT0059"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>GC</given-names></name><name><surname>Nakada</surname><given-names>N</given-names></name><name><surname>Yamashita</surname><given-names>N</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name></person-group><article-title>Occurrence and fate of oseltamivir carboxylate (Tamiflu) and amantadine in sewage treatment plants</article-title><source>Chemosphere</source><year>2010</year><volume>81</volume><fpage>13</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">20692015</pub-id></element-citation></ref><ref id="CIT0060"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azuma</surname><given-names>T</given-names></name><name><surname>Nakada</surname><given-names>N</given-names></name><name><surname>Yamashita</surname><given-names>N</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name></person-group><article-title>Mass balance of anti-influenza drugs discharged into the Yodo River system, Japan, under an influenza outbreak</article-title><source>Chemosphere</source><year>2013</year><volume>93</volume><fpage>1672</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">23871592</pub-id></element-citation></ref><ref id="CIT0061"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>AC</given-names></name><name><surname>Järhult</surname><given-names>JD</given-names></name><name><surname>Grabic</surname><given-names>R</given-names></name><name><surname>Khan</surname><given-names>GA</given-names></name><name><surname>Fedorova</surname><given-names>G</given-names></name><name><surname>Fick</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Compliance to oseltamivir among two populations in Oxfordshire, United Kingdom affected by influenza A(H1N1)pdm09, November 2009 – a waste water epidemiology study</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e60221</fpage><pub-id pub-id-type="pmid">23613721</pub-id></element-citation></ref><ref id="CIT0062"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goncalves</surname><given-names>C</given-names></name><name><surname>Perez</surname><given-names>S</given-names></name><name><surname>Osorio</surname><given-names>V</given-names></name><name><surname>Petrovic</surname><given-names>M</given-names></name><name><surname>Alpendurada</surname><given-names>MF</given-names></name><name><surname>Barcelo</surname><given-names>D</given-names></name></person-group><article-title>Photofate of oseltamivir (Tamiflu) and oseltamivir carboxylate under natural and simulated solar irradiation: kinetics, identification of the transformation products, and environmental occurrence</article-title><source>Environ Sci Technol</source><year>2011</year><volume>45</volume><fpage>4307</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">21495632</pub-id></element-citation></ref><ref id="CIT0063"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>WY</given-names></name><name><surname>Lin</surname><given-names>CJ</given-names></name><name><surname>Liao</surname><given-names>CM</given-names></name></person-group><article-title>Assessing exposure risks for aquatic organisms posed by Tamiflu use under seasonal influenza and pandemic conditions</article-title><source>Environ Pollut</source><year>2014</year><volume>184</volume><fpage>377</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">24095813</pub-id></element-citation></ref><ref id="CIT0064"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Straub</surname><given-names>JO</given-names></name></person-group><article-title>An environmental risk assessment for oseltamivir (Tamiflu) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions</article-title><source>Ecotoxicol Environ Saf</source><year>2009</year><volume>72</volume><fpage>1625</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">19560203</pub-id></element-citation></ref><ref id="CIT0065"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>AC</given-names></name><name><surname>Johnson</surname><given-names>AC</given-names></name><name><surname>Anderson</surname><given-names>PD</given-names></name><name><surname>Snyder</surname><given-names>SA</given-names></name></person-group><article-title>Reassessing the risks of Tamiflu use during a pandemic to the Lower Colorado River</article-title><source>Environ Health Perspect</source><year>2008</year><volume>116</volume><fpage>A285</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">18629328</pub-id></element-citation></ref><ref id="CIT0066"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>AC</given-names></name><name><surname>Nunn</surname><given-names>MA</given-names></name><name><surname>Gould</surname><given-names>EA</given-names></name><name><surname>Johnson</surname><given-names>AC</given-names></name></person-group><article-title>Potential risks associated with the proposed widespread use of Tamiflu</article-title><source>Environ Health Perspect</source><year>2007</year><volume>115</volume><fpage>102</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17366827</pub-id></element-citation></ref><ref id="CIT0067"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartels</surname><given-names>P</given-names></name><name><surname>von Tumpling</surname><given-names>W</given-names><suffix>Jr</suffix></name></person-group><article-title>The environmental fate of the antiviral drug oseltamivir carboxylate in different waters</article-title><source>Sci Total Environ</source><year>2008</year><volume>405</volume><fpage>215</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">18675443</pub-id></element-citation></ref><ref id="CIT0068"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boreen</surname><given-names>AL</given-names></name><name><surname>Arnold</surname><given-names>WA</given-names></name><name><surname>McNeill</surname><given-names>K</given-names></name></person-group><article-title>Photodegradation of pharmaceuticals in the aquatic environment: a review</article-title><source>Aquat Sci</source><year>2003</year><volume>65</volume><fpage>320</fpage><lpage>41</lpage></element-citation></ref><ref id="CIT0069"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Accinelli</surname><given-names>C</given-names></name><name><surname>Sacca</surname><given-names>ML</given-names></name><name><surname>Fick</surname><given-names>J</given-names></name><name><surname>Mencarelli</surname><given-names>M</given-names></name><name><surname>Lindberg</surname><given-names>R</given-names></name><name><surname>Olsen</surname><given-names>B</given-names></name></person-group><article-title>Dissipation and removal of oseltamivir (Tamiflu) in different aquatic environments</article-title><source>Chemosphere</source><year>2010</year><volume>79</volume><fpage>891</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">20226496</pub-id></element-citation></ref><ref id="CIT0070"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Accinelli</surname><given-names>C</given-names></name><name><surname>Caracciolo</surname><given-names>AB</given-names></name><name><surname>Grenni</surname><given-names>P</given-names></name></person-group><article-title>Degradation of the antiviral drug oseltamivir carboxylate in surface water samples</article-title><source>Int J Environ Anal Chem</source><year>2007</year><volume>87</volume><fpage>579</fpage><lpage>87</lpage></element-citation></ref><ref id="CIT0071"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slater</surname><given-names>FR</given-names></name><name><surname>Singer</surname><given-names>AC</given-names></name><name><surname>Turner</surname><given-names>S</given-names></name><name><surname>Barr</surname><given-names>JJ</given-names></name><name><surname>Bond</surname><given-names>PL</given-names></name></person-group><article-title>Pandemic pharmaceutical dosing effects on wastewater treatment: no adaptation of activated sludge bacteria to degrade the antiviral drug oseltamivir (Tamiflu(R)) and loss of nutrient removal performance</article-title><source>FEMS Microbiol Lett</source><year>2011</year><volume>315</volume><fpage>17</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">21133989</pub-id></element-citation></ref><ref id="CIT0072"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacca</surname><given-names>ML</given-names></name><name><surname>Accinelli</surname><given-names>C</given-names></name><name><surname>Fick</surname><given-names>J</given-names></name><name><surname>Lindberg</surname><given-names>R</given-names></name><name><surname>Olsen</surname><given-names>B</given-names></name></person-group><article-title>Environmental fate of the antiviral drug Tamiflu in two aquatic ecosystems</article-title><source>Chemosphere</source><year>2009</year><volume>75</volume><fpage>28</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">19124147</pub-id></element-citation></ref><ref id="CIT0073"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Accinelli</surname><given-names>C</given-names></name><name><surname>Saccà</surname><given-names>ML</given-names></name><name><surname>Batisson</surname><given-names>I</given-names></name><name><surname>Fick</surname><given-names>J</given-names></name><name><surname>Mencarelli</surname><given-names>M</given-names></name><name><surname>Grabic</surname><given-names>R</given-names></name></person-group><article-title>Removal of oseltamivir (Tamiflu) and other selected pharmaceuticals from wastewater using a granular bioplastic formulation entrapping propagules of Phanerochaete chrysosporium</article-title><source>Chemosphere</source><year>2010</year><volume>81</volume><fpage>436</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">20673959</pub-id></element-citation></ref><ref id="CIT0074"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mestankova</surname><given-names>H</given-names></name><name><surname>Schirmer</surname><given-names>K</given-names></name><name><surname>Escher</surname><given-names>BI</given-names></name><name><surname>von Gunten</surname><given-names>U</given-names></name><name><surname>Canonica</surname><given-names>S</given-names></name></person-group><article-title>Removal of the antiviral agent oseltamivir and its biological activity by oxidative processes</article-title><source>Environ Pollut</source><year>2012</year><volume>161</volume><fpage>30</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">22230064</pub-id></element-citation></ref><ref id="CIT0075"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fedorova</surname><given-names>G</given-names></name><name><surname>Grabic</surname><given-names>R</given-names></name><name><surname>Nyhlen</surname><given-names>J</given-names></name><name><surname>Järhult</surname><given-names>JD</given-names></name><name><surname>Söderström</surname><given-names>H</given-names></name></person-group><article-title>Fate of three anti-influenza drugs during ozonation of wastewater effluents – degradation and formation of transformation products</article-title><source>Chemosphere</source><year>2016</year><volume>150</volume><fpage>723</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">26746418</pub-id></element-citation></ref><ref id="CIT0076"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munster</surname><given-names>VJ</given-names></name><name><surname>Baas</surname><given-names>C</given-names></name><name><surname>Lexmond</surname><given-names>P</given-names></name><name><surname>Waldenström</surname><given-names>J</given-names></name><name><surname>Wallensten</surname><given-names>A</given-names></name><name><surname>Fransson</surname><given-names>T</given-names></name><etal></etal></person-group><article-title>Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds</article-title><source>PLoS Pathog</source><year>2007</year><volume>3</volume><fpage>e61</fpage><pub-id pub-id-type="pmid">17500589</pub-id></element-citation></ref><ref id="CIT0077"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krauss</surname><given-names>S</given-names></name><name><surname>Walker</surname><given-names>D</given-names></name><name><surname>Pryor</surname><given-names>SP</given-names></name><name><surname>Niles</surname><given-names>L</given-names></name><name><surname>Chenghong</surname><given-names>L</given-names></name><name><surname>Hinshaw</surname><given-names>VS</given-names></name><etal></etal></person-group><article-title>2004. Influenza A viruses of migrating wild aquatic birds in North America</article-title><source>Vector Borne Zoonotic Dis</source><year>2004</year><volume>4</volume><fpage>177</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">15631061</pub-id></element-citation></ref><ref id="CIT0078"><label>78</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fouchier</surname><given-names>RAM</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Webster</surname><given-names>RG</given-names></name><name><surname>Monto</surname><given-names>AS</given-names></name><name><surname>Braciale</surname><given-names>TJ</given-names></name><name><surname>Lamb</surname><given-names>RA</given-names></name></person-group><article-title>Ecology and evolution of influenza viruses in wild and domesticated birds</article-title><source>Textbook of influenza</source><year>2013</year><publisher-loc>Oxford, UK</publisher-loc><publisher-name>Wiley</publisher-name><fpage>175</fpage><lpage>89</lpage></element-citation></ref><ref id="CIT0079"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latorre-Margalef</surname><given-names>N</given-names></name><name><surname>Tolf</surname><given-names>C</given-names></name><name><surname>Grosbois</surname><given-names>V</given-names></name><name><surname>Avril</surname><given-names>A</given-names></name><name><surname>Bengtsson</surname><given-names>D</given-names></name><name><surname>Wille</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Long-term variation in influenza A virus prevalence and subtype diversity in migratory mallards in northern Europe</article-title><source>Proc Biol Sci</source><year>2014</year><volume>281</volume><fpage>20140098</fpage><pub-id pub-id-type="pmid">24573857</pub-id></element-citation></ref><ref id="CIT0080"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaidet</surname><given-names>N</given-names></name><name><surname>Ould El Mamy</surname><given-names>AB</given-names></name><name><surname>Cappelle</surname><given-names>J</given-names></name><name><surname>Caron</surname><given-names>A</given-names></name><name><surname>Cumming</surname><given-names>GS</given-names></name><name><surname>Grosbois</surname><given-names>V</given-names></name><etal></etal></person-group><article-title>Investigating avian influenza infection hotspots in old-world shorebirds</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e46049</fpage><pub-id pub-id-type="pmid">23029383</pub-id></element-citation></ref><ref id="CIT0081"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krauss</surname><given-names>S</given-names></name><name><surname>Stallknecht</surname><given-names>DE</given-names></name><name><surname>Negovetich</surname><given-names>NJ</given-names></name><name><surname>Niles</surname><given-names>LJ</given-names></name><name><surname>Webby</surname><given-names>RJ</given-names></name><name><surname>Webster</surname><given-names>RG</given-names></name></person-group><article-title>Coincident ruddy turnstone migration and horseshoe crab spawning creates an ecological ‘hot spot’ for influenza viruses</article-title><source>Proc Biol Sci</source><year>2010</year><volume>277</volume><fpage>3373</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">20630885</pub-id></element-citation></ref><ref id="CIT0082"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jourdain</surname><given-names>E</given-names></name><name><surname>Gunnarsson</surname><given-names>G</given-names></name><name><surname>Wahlgren</surname><given-names>J</given-names></name><name><surname>Latorre-Margalef</surname><given-names>N</given-names></name><name><surname>Bröjer</surname><given-names>C</given-names></name><name><surname>Sahlin</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Influenza virus in a natural host, the mallard: experimental infection data</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><fpage>e8935</fpage><pub-id pub-id-type="pmid">20126617</pub-id></element-citation></ref><ref id="CIT0083"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latorre-Margalef</surname><given-names>N</given-names></name><name><surname>Gunnarsson</surname><given-names>G</given-names></name><name><surname>Munster</surname><given-names>VJ</given-names></name><name><surname>Fouchier</surname><given-names>RA</given-names></name><name><surname>Osterhaus</surname><given-names>AD</given-names></name><name><surname>Elmberg</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Effects of influenza A virus infection on migrating mallard ducks</article-title><source>Proc Biol Sci</source><year>2009</year><volume>276</volume><fpage>1029</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">19129127</pub-id></element-citation></ref><ref id="CIT0084"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallensten</surname><given-names>A</given-names></name><name><surname>Munster</surname><given-names>VJ</given-names></name><name><surname>Karlsson</surname><given-names>M</given-names></name><name><surname>Lundkvist</surname><given-names>Å</given-names></name><name><surname>Brytting</surname><given-names>M</given-names></name><name><surname>Stervander</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>High prevalence of influenza A virus in ducks caught during spring migration through Sweden</article-title><source>Vaccine</source><year>2006</year><volume>24</volume><fpage>6734</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">16815603</pub-id></element-citation></ref><ref id="CIT0085"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>NJ</given-names></name><name><surname>Takekawa</surname><given-names>JY</given-names></name><name><surname>Ackerman</surname><given-names>JT</given-names></name><name><surname>Hobson</surname><given-names>KA</given-names></name><name><surname>Herring</surname><given-names>G</given-names></name><name><surname>Cardona</surname><given-names>CJ</given-names></name><etal></etal></person-group><article-title>Migration strategy affects avian influenza dynamics in mallards (<italic>Anas platyrhynchos</italic>)</article-title><source>Mol Ecol</source><year>2012</year><volume>21</volume><fpage>5986</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">22971007</pub-id></element-citation></ref><ref id="CIT0086"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>NS</given-names></name><name><surname>Verhagen</surname><given-names>JH</given-names></name><name><surname>Javakhishvili</surname><given-names>Z</given-names></name><name><surname>Russell</surname><given-names>CA</given-names></name><name><surname>Lexmond</surname><given-names>P</given-names></name><name><surname>Westgeest</surname><given-names>KB</given-names></name><etal></etal></person-group><article-title>Influenza A virus evolution and spatio-temporal dynamics in Eurasian wild birds: a phylogenetic and phylogeographical study of whole-genome sequence data</article-title><source>J Gen Virol</source><year>2015</year><volume>96</volume><fpage>2050</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">25904147</pub-id></element-citation></ref><ref id="CIT0087"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dugan</surname><given-names>VG</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Spiro</surname><given-names>DJ</given-names></name><name><surname>Sengamalay</surname><given-names>N</given-names></name><name><surname>Zaborsky</surname><given-names>J</given-names></name><name><surname>Ghedin</surname><given-names>E</given-names></name><etal></etal></person-group><article-title>The evolutionary genetics and emergence of avian influenza viruses in wild birds</article-title><source>PLoS Pathog</source><year>2008</year><volume>4</volume><fpage>e1000076</fpage><pub-id pub-id-type="pmid">18516303</pub-id></element-citation></ref><ref id="CIT0088"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Holmes</surname><given-names>EC</given-names></name></person-group><article-title>Hitchhiking and the population genetic structure of avian influenza virus</article-title><source>J Mol Evol</source><year>2010</year><volume>70</volume><fpage>98</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">20041240</pub-id></element-citation></ref><ref id="CIT0089"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>CA</given-names></name><name><surname>Fonville</surname><given-names>JM</given-names></name><name><surname>Brown</surname><given-names>AE</given-names></name><name><surname>Burke</surname><given-names>DF</given-names></name><name><surname>Smith</surname><given-names>DL</given-names></name><name><surname>James</surname><given-names>SL</given-names></name><etal></etal></person-group><article-title>The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host</article-title><source>Science</source><year>2012</year><volume>336</volume><fpage>1541</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22723414</pub-id></element-citation></ref><ref id="CIT0090"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Holmes</surname><given-names>EC</given-names></name></person-group><article-title>Avian influenza virus exhibits rapid evolutionary dynamics</article-title><source>Mol Biol Evol</source><year>2006</year><volume>23</volume><fpage>2336</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">16945980</pub-id></element-citation></ref><ref id="CIT0091"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forrest</surname><given-names>HL</given-names></name><name><surname>Webster</surname><given-names>RG</given-names></name></person-group><article-title>Perspectives on influenza evolution and the role of research</article-title><source>Anim Health Res Rev</source><year>2010</year><volume>11</volume><fpage>3</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">20591210</pub-id></element-citation></ref><ref id="CIT0092"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Järhult</surname><given-names>JD</given-names></name><name><surname>Muradrasoli</surname><given-names>S</given-names></name><name><surname>Wahlgren</surname><given-names>J</given-names></name><name><surname>Söderström</surname><given-names>H</given-names></name><name><surname>Orozovic</surname><given-names>G</given-names></name><name><surname>Gunnarsson</surname><given-names>G</given-names></name><etal></etal></person-group><article-title>Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e24742</fpage><pub-id pub-id-type="pmid">21931841</pub-id></element-citation></ref><ref id="CIT0093"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Achenbach</surname><given-names>JE</given-names></name><name><surname>Bowen</surname><given-names>RA</given-names></name></person-group><article-title>Effect of oseltamivir carboxylate consumption on emergence of drug-resistant H5N2 avian influenza virus in Mallard ducks</article-title><source>Antimicrob Agents Chemother</source><year>2013</year><volume>57</volume><fpage>2171</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">23459475</pub-id></element-citation></ref><ref id="CIT0094"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillman</surname><given-names>A</given-names></name><name><surname>Muradrasoli</surname><given-names>S</given-names></name><name><surname>Söderström</surname><given-names>H</given-names></name><name><surname>Nordh</surname><given-names>J</given-names></name><name><surname>Bröjer</surname><given-names>C</given-names></name><name><surname>Lindberg</surname><given-names>RH</given-names></name><etal></etal></person-group><article-title>Resistance mutation R292K is induced in influenza A(H6N2) virus by exposure of infected mallards to low levels of oseltamivir</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e71230</fpage><pub-id pub-id-type="pmid">23951116</pub-id></element-citation></ref><ref id="CIT0095"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillman</surname><given-names>A</given-names></name><name><surname>Nykvist</surname><given-names>M</given-names></name><name><surname>Muradrasoli</surname><given-names>S</given-names></name><name><surname>Söderström</surname><given-names>H</given-names></name><name><surname>Wille</surname><given-names>M</given-names></name><name><surname>Daggfeldt</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Influenza A(H7N9) virus acquires resistance-related neuraminidase I222T substitution when infected mallards are exposed to low levels of oseltamivir in water</article-title><source>Antimicrob Agents Chemother</source><year>2015</year><volume>59</volume><fpage>5196</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">26077257</pub-id></element-citation></ref><ref id="CIT0096"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillman</surname><given-names>A</given-names></name><name><surname>Muradrasoli</surname><given-names>S</given-names></name><name><surname>Söderström</surname><given-names>H</given-names></name><name><surname>Holmberg</surname><given-names>F</given-names></name><name><surname>Latorre-Margalef</surname><given-names>N</given-names></name><name><surname>Tolf</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Oseltamivir-resistant influenza A (H1N1) virus strain with an H274Y mutation in neuraminidase persists without drug pressure in infected mallards</article-title><source>Appl Environ Microbiol</source><year>2015</year><volume>81</volume><fpage>2378</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">25616792</pub-id></element-citation></ref><ref id="CIT0097"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillman</surname><given-names>A</given-names></name><name><surname>Muradrasoli</surname><given-names>S</given-names></name><name><surname>Mardnas</surname><given-names>A</given-names></name><name><surname>Söderström</surname><given-names>H</given-names></name><name><surname>Fedorova</surname><given-names>G</given-names></name><name><surname>Lowenthal</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Oseltamivir resistance in influenza A(H6N2) caused by an R292K substitution in neuraminidase is not maintained in mallards without drug pressure</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e0139415</fpage><pub-id pub-id-type="pmid">26422258</pub-id></element-citation></ref><ref id="CIT0098"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>JD</given-names></name><name><surname>Gong</surname><given-names>LI</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name></person-group><article-title>Permissive secondary mutations enable the evolution of influenza oseltamivir resistance</article-title><source>Science</source><year>2010</year><volume>328</volume><fpage>1272</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">20522774</pub-id></element-citation></ref><ref id="CIT0099"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>S</given-names></name><name><surname>Govorkova</surname><given-names>EA</given-names></name><name><surname>Bahl</surname><given-names>J</given-names></name><name><surname>Zaraket</surname><given-names>H</given-names></name><name><surname>Baranovich</surname><given-names>T</given-names></name><name><surname>Seiler</surname><given-names>P</given-names></name><etal></etal></person-group><article-title>Epistatic interactions between neuraminidase mutations facilitated the emergence of the oseltamivir-resistant H1N1 influenza viruses</article-title><source>Nat Commun</source><year>2014</year><volume>5</volume><fpage>5029</fpage><pub-id pub-id-type="pmid">25297528</pub-id></element-citation></ref><ref id="CIT0100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>J</given-names></name><name><surname>Hooper</surname><given-names>KA</given-names></name><name><surname>Petrie</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>R</given-names></name><name><surname>Maurer-Stroh</surname><given-names>S</given-names></name><name><surname>Reh</surname><given-names>L</given-names></name><etal></etal></person-group><article-title>Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses</article-title><source>PLoS Pathog</source><year>2014</year><volume>10</volume><fpage>e1004065</fpage><pub-id pub-id-type="pmid">24699865</pub-id></element-citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D70 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000D70 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.33. |  |